{"protocolSection": {"identificationModule": {"nctId": "NCT01171625", "orgStudyIdInfo": {"id": "2007-08"}, "organization": {"fullName": "Edwards Lifesciences", "class": "INDUSTRY"}, "briefTitle": "Carpentier-Edwards PERIMOUNT Magna Ease Pericardial Bioprosthesis, Model 3300TFX", "officialTitle": "Carpentier-Edwards PERIMOUNT Magna Ease Pericardial Bioprosthesis in the Aortic Position, Model 3300TFX"}, "statusModule": {"statusVerifiedDate": "2020-04", "overallStatus": "COMPLETED", "expandedAccessInfo": {"hasExpandedAccess": false}, "startDateStruct": {"date": "2007-10", "type": "ACTUAL"}, "primaryCompletionDateStruct": {"date": "2018-09", "type": "ACTUAL"}, "completionDateStruct": {"date": "2018-09", "type": "ACTUAL"}, "studyFirstSubmitDate": "2010-07-26", "studyFirstSubmitQcDate": "2010-07-27", "studyFirstPostDateStruct": {"date": "2010-07-28", "type": "ESTIMATED"}, "resultsFirstSubmitDate": "2020-02-06", "resultsFirstSubmitQcDate": "2020-04-07", "resultsFirstPostDateStruct": {"date": "2020-04-17", "type": "ACTUAL"}, "lastUpdateSubmitDate": "2020-04-07", "lastUpdatePostDateStruct": {"date": "2020-04-17", "type": "ACTUAL"}}, "sponsorCollaboratorsModule": {"responsibleParty": {"type": "SPONSOR"}, "leadSponsor": {"name": "Edwards Lifesciences", "class": "INDUSTRY"}}, "oversightModule": {"oversightHasDmc": false, "isFdaRegulatedDrug": false, "isFdaRegulatedDevice": true, "isUsExport": true}, "descriptionModule": {"briefSummary": "The purpose of the study is to demonstrate the long term safety and effectiveness of the Carpentier-Edwards PERIMOUNT Magna Ease Valves in patients undergoing aortic valve replacement with or without concomitant procedures requiring cardiopulmonary bypass.", "detailedDescription": "This is a prospective, single-arm, multi-center, interventional study to be conducted in the US and outside the US (OUS). This study will enroll a minimum of 225 patients implanted with the study valve in order to achieve 101 aortic valve replacement subjects each followed for a minimum of 8 years. The study will include male and female patients, 18 years or older, requiring replacement for a diseased, damaged or malfunctioning natural or prosthetic aortic valve. Patients will be followed and assessed after implant at discharge, 6 months, one year, and annually for a minimum of 8 years."}, "conditionsModule": {"conditions": ["Coronary Artery Disease", "Aortic Valve Disorder", "Heart Failure", "Aortic Valve Stenosis", "Aortic Valve Insufficiency"], "keywords": ["PERIMOUNT, Aortic valve replacement/regurgitation"]}, "designModule": {"studyType": "INTERVENTIONAL", "phases": ["NA"], "designInfo": {"allocation": "NA", "interventionModel": "SINGLE_GROUP", "primaryPurpose": "TREATMENT", "maskingInfo": {"masking": "NONE"}}, "enrollmentInfo": {"count": 283, "type": "ACTUAL"}}, "armsInterventionsModule": {"armGroups": [{"label": "CEP Aortic Bioprothesis, model 3300TFX", "type": "OTHER", "interventionNames": ["Device: Implantation of CEP Magna Ease Model 3300TFX"]}], "interventions": [{"type": "DEVICE", "name": "Implantation of CEP Magna Ease Model 3300TFX", "description": "Heart Valve Surgery", "armGroupLabels": ["CEP Aortic Bioprothesis, model 3300TFX"], "otherNames": ["CEP Magna Ease MOdel 3300TFX"]}]}, "outcomesModule": {"primaryOutcomes": [{"measure": "Subject's Percentage of Long Term Safety Performance", "description": "Long term safety performance will be evaluated by comparing the linearized yearly rates to the objective performance criteria (OPC) referenced in the Food and Drug Administration (FDA) 1994 Draft Heart Valve Guidance.\n\nExpressed as the Number of late events divided by the total number of late patient years times 100. Late patient years are calculated from 31 days post-implant to the date of the last contact (follow up or adverse event).", "timeFrame": "31 days through 8 years post-implant"}, {"measure": "Number of Subject's in NYHA Functional Class I or II at 8 Year Post-Implant", "description": "The New York Heart Association (NYHA) functional classification system relates symptoms to everyday activities and the patient's quality of life.\n\nClass I. No limitation of physical activity. Ordinary physical activity does not cause undue fatigue, palpitation, dyspnea (shortness of breath).\n\nClass II. Slight limitation of physical activity. Comfortable at rest. Ordinary physical activity results in fatigue, palpitation, dyspnea (shortness of breath).", "timeFrame": "8 years post-implant"}, {"measure": "Subject's New York Heart Association (NYHA) Functional Class at 8 Years Post-Implant Compared to Baseline", "description": "The New York Heart Association (NYHA) functional classification system relates symptoms to everyday activities and the patient's quality of life.\n\nClass I. No limitation of physical activity. Ordinary physical activity does not cause undue fatigue, palpitation, dyspnea (shortness of breath).\n\nClass II. Slight limitation of physical activity. Comfortable at rest. Ordinary physical activity results in fatigue, palpitation, dyspnea (shortness of breath).\n\nClass III. Marked limitation of physical activity. Comfortable at rest. Less than ordinary activity causes fatigue, palpitation, or dyspnea.\n\nClass IV. Unable to carry on any physical activity without discomfort. Symptoms of heart failure at rest. If any physical activity is undertaken, discomfort increases.", "timeFrame": "8 Years post-implant"}], "secondaryOutcomes": [{"measure": "Percent of Early Adverse Events", "description": "Number of early adverse events occurring within 30 days of procedure divided by the number of enrolled subjects times 100.", "timeFrame": "Events occurring within 30 days of procedure"}, {"measure": "Percentage of Late Adverse Events", "description": "Number of late events divided by the total number of late patient years times 100. Late patient years are calculated from 31 days post-implant to the date of the last contact (follow up or adverse event).", "timeFrame": "Events occurring >= 31 days and up through 8 years post-implant"}, {"measure": "Percent of Subjects With Freedom From Serious Adverse Events (SAE) Post-implant > 30 Days", "description": "Subject's freedom from Serious Adverse Events at \\> 30 days post-implant. Time to events were estimated by Kaplan-Meier method.", "timeFrame": "1 Year, 2 Years, 3 Years, 4 Years, 5 Years, 6 Years, 7 Years, and 8 Years post-implant"}, {"measure": "Subject's Average Peak Systolic Gradient (mmHg) Measurements at 8 Years Post-implant", "description": "Peak systolic gradient is the maximum value measured of flow of blood through the aortic valve as measured in millimeters of mercury. The data summary will be stratified by valve size.", "timeFrame": "8 years post-implant"}, {"measure": "Subject's Average Mean Systolic Gradient (mmHg) Measurements at 8 Years Post-implant.", "description": "Mean systolic gradient is the average flow of blood through the aortic valve measured in millimeters of mercury. Mean gradient values depend on the size and type of valve. The data summary will be stratified by valve size.", "timeFrame": "8 years post-implant"}, {"measure": "Subject's Average Effective Orifice Area Measurements at 8 Years Post-implant.", "description": "Effective orifice area represents the cross-sectional area of the blood flow downstream of the aortic valve. The data summary will be stratified by valve size.", "timeFrame": "8 years post-implant"}, {"measure": "Subject's Average Effective Orifice Area Index (EOAI) Measurements at 8 Years Post-implant.", "description": "Effective orifice area index represents the minimal cross-sectional area of the blood flow downstream of the aortic valve divided by the person's body surface area. The data summary will be stratified by valve size.", "timeFrame": "8 years post-implant"}, {"measure": "Subject's Average Performance Index Measurements at 8 Years Post-implant.", "description": "Performance index is defined as the subject's effective orifice area (the cross-sectional area of the blood flow downstream of the aortic valve) divided by the subject's native orifice area. The data summary will be stratified by valve size.", "timeFrame": "8 years post-implant"}, {"measure": "Subject's Average Cardiac Output Measurements at 8 Years Post-implant.", "description": "The amount of blood the heart pumps through the circulatory system in a minute. The data summary will be stratified by valve size.", "timeFrame": "8 years post-implant"}, {"measure": "Subject's Average Cardiac Index Measurements at 8 Years Post-implant.", "description": "Cardiac index is an assessment that divides the cardiac output from left ventricle in one minute by the person's body surface area (BSA), thus relating heart performance to the size of the individual. The data summary will be stratified by valve size.", "timeFrame": "8 years post-implant"}, {"measure": "Subject's Amount of Aortic Valvular Regurgitation at 8 Years Post-Implant.", "description": "Aortic valvular regurgitation occurs when the aortic valve in the heart does not close tightly allowing some of the blood that was pumped out of the heart to leak back into it. Aortic valvular regurgitation is evaluated by echocardiography over time. It is assessed on a scale from 0 to 4, where 0 represents no regurgitation and 4 represents severe regurgitation.", "timeFrame": "8 years post-implant"}, {"measure": "Subject's Average White Blood Cell Count Measurement Over Time.", "description": "Laboratory analysis of White Blood Cell Count on blood drawn from subject; WBC fight infection.", "timeFrame": "6 months and annually for 8 years post-implant"}, {"measure": "Subject's Average Red Blood Cells Count Over Time.", "description": "Laboratory Analysis of Red Blood Cell (RBC) Count on blood drawn from subjects; RBC carry oxygen.", "timeFrame": "6 months and annually for 8 years post-implant"}, {"measure": "Subject's Average Hematocrit Percentage Over Time.", "description": "Laboratory Analysis of Hematocrit Percentage on blood drawn from subjects. Hematocrit is the proportion of red blood cells to the fluid component (plasma) in the blood.", "timeFrame": "6 months and annually for 8 years post-implant"}, {"measure": "Subject's Average Hemoglobin Count Over Time.", "description": "Laboratory Analysis of Hemoglobin Count on blood drawn from subjects. Hemoglobin is an oxygen-carrying protein in red blood cells.", "timeFrame": "6 months and annually for 8 years post-implant"}, {"measure": "Subject's Average Platelet Count Over Time.", "description": "Laboratory Analysis of Platelet Count on blood drawn from subjects; platelets help with blood clotting.", "timeFrame": "6 months and annually for 8 years post-implant"}, {"measure": "Subject's Average Serum Lactate Dehydrogenase (LDH) Over Time.", "description": "Laboratory Analysis of Serum Lactate Dehydrogenase on blood drawn from subjects; The lactate dehydrogenase (LDH) test looks for signs of damage to the body's tissues.", "timeFrame": "6 months and annually for 8 years post-implant"}, {"measure": "Subject's Average Haptoglobin Measurement Over Time.", "description": "Laboratory Analysis of haptoglobin on blood drawn from subjects; haptoglobin is a protein produced by the liver.", "timeFrame": "6 months and annually for 8 years post-implant"}, {"measure": "Subject's Average Reticulocytes Percentage Over Time.", "description": "Laboratory Analysis of reticulocytes on blood drawn from subjects. Reticulocytes are newly produced immature red blood cells; a reticulocyte blood test measures the amount of these cells in the blood.", "timeFrame": "6 months and annually for 8 years post-implant"}, {"measure": "Subject's Average Score on the EQ-5D- Quality of Life Questionnaire at Baseline and 6 Months Post-Implant.", "description": "The EQ-5D is a standardized questionnaire that asks subjects to rate themselves (no problems, some problems, extreme problems) on mobility, self-care, usual activities, pain/discomfort, and anxiety/depression. The scale ranges from a minimum of 0 and a maximum of 100 where zero is the 'worst state imaginable' and 100 is the 'best state imaginable'.", "timeFrame": "Baseline and 6 Months Post-Implant"}]}, "eligibilityModule": {"eligibilityCriteria": "Inclusion Criteria:\n\n1. The patient requires, as indicated in the preoperative evaluation, a replacement aortic valve.\n2. The patient is an average or better operative risk.\n3. The patient is geographically stable and agrees to attend follow-up assessments at the hospital of surgical services for at least 8 years.\n4. The patient is 18 years or older.\n5. The patient has signed and dated the subject informed consent form prior to surgery.\n\nExclusion Criteria:\n\n1. The patient has any known non-cardiac life-threatening disease, which will limit the patient's life expectancy below 1 year.\n2. The patient presents with active endocarditis within the last 3 months.\n3. The patient has an abnormal calcium metabolism (e.g., chronic renal failure, hyperparathyroidism).\n4. The patient has an aneurismal aortic degenerative condition (e.g., cystic medial necrosis, Marfan's syndrome).\n5. The patient is pregnant or lactating.\n6. The patient is an intravenous drug abuser.\n7. The patient is currently a prison inmate.\n8. The patient is currently participating in a study of an investigational drug or device.\n9. The patient requires replacement of a native or prosthetic mitral, tricuspid or pulmonic valve.\n10. The patient requires a repair of the mitral or tricuspid valve with the use of an annuloplasty device.\n11. The patient was previously enrolled in the study.\n12. The patient had a prior mitral, tricuspid or pulmonic valve surgery, which included implantation of a bioprosthetic valve, mechanical valve, or annuloplasty ring that will remain in situ.", "healthyVolunteers": false, "sex": "ALL", "minimumAge": "18 Years", "stdAges": ["ADULT", "OLDER_ADULT"]}, "contactsLocationsModule": {"locations": [{"facility": "Mercy General Hospital", "city": "Sacramento", "state": "California", "zip": "95819", "country": "United States", "geoPoint": {"lat": 38.58157, "lon": -121.4944}}, {"facility": "Cooper University Hospital", "city": "Camden", "state": "New Jersey", "zip": "08103", "country": "United States", "geoPoint": {"lat": 39.92595, "lon": -75.11962}}, {"facility": "Morristown Memorial Hospital", "city": "Morristown", "state": "New Jersey", "zip": "09762", "country": "United States", "geoPoint": {"lat": 40.79677, "lon": -74.48154}}, {"facility": "Providence Heart & Vascular Institute", "city": "Portland", "state": "Oregon", "zip": "97225", "country": "United States", "geoPoint": {"lat": 45.52345, "lon": -122.67621}}, {"facility": "St. Marks Hospital", "city": "Salt Lake City", "state": "Utah", "zip": "84124", "country": "United States", "geoPoint": {"lat": 40.76078, "lon": -111.89105}}, {"facility": "Universitatslinik fur Chirurgie", "city": "Innsbruck", "zip": "6020", "country": "Austria", "geoPoint": {"lat": 47.26266, "lon": 11.39454}}, {"facility": "Sunnybrook Health Sciences Centre", "city": "Toronto", "state": "Ontario", "zip": "M4N 3M5", "country": "Canada", "geoPoint": {"lat": 43.70011, "lon": -79.4163}}, {"facility": "St. Paul's Hospital", "city": "Vancouver", "zip": "V6Z 1Y6", "country": "Canada", "geoPoint": {"lat": 49.24966, "lon": -123.11934}}, {"facility": "Liknik fur Herz und BefaBchirurgie Im Deuschen Herzzentrum", "city": "Munich", "state": "Lazarettstr", "zip": "36", "country": "Germany", "geoPoint": {"lat": 48.13743, "lon": 11.57549}}, {"facility": "Klinik fur Herz-, Thorax-, Transplantations- und Gefabchirurgie", "city": "Hannover", "zip": "D-30625", "country": "Germany", "geoPoint": {"lat": 52.37052, "lon": 9.73322}}, {"facility": "Hospital Peutra de Hierro", "city": "San Martin de Porres 4", "state": "Madrid", "zip": "CP-28035", "country": "Spain", "geoPoint": {"lat": 43.02022, "lon": -3.73364}}, {"facility": "Papworth Hospital NHS foundation Trust", "city": "Papworth Everard", "state": "Cambridge", "zip": "CV23 3RE", "country": "United Kingdom", "geoPoint": {"lat": 52.24893, "lon": -0.11827}}, {"facility": "Blackpool Victoria Hospital", "city": "Blackpool", "state": "Lancashire", "zip": "FY8 8NR", "country": "United Kingdom", "geoPoint": {"lat": 53.81667, "lon": -3.05}}]}, "referencesModule": {"references": [{"pmid": "29912142", "type": "RESULT", "citation": "Wahlers TCW, Andreas M, Rahmanian P, Candolfi P, Zemanova B, Giot C, Ferrari E, Laufer G. Outcomes of a Rapid Deployment Aortic Valve Versus Its Conventional Counterpart: A Propensity-Matched Analysis. Innovations (Phila). 2018 May/Jun;13(3):177-183. doi: 10.1097/IMI.0000000000000509."}], "seeAlsoLinks": [{"label": "New York Heart Association Classification", "url": "https://www.heart.org/en/health-topics/heart-failure/what-is-heart-failure/classes-of-heart-failure"}]}}, "resultsSection": {"participantFlowModule": {"groups": [{"id": "FG000", "title": "Carpentier-Edwards\u00ae PERIMOUNT\u00ae Magna Ease\u2122, Model 3300TFX", "description": "Subjects who received the Carpentier-Edwards\u00ae PERIMOUNT\u00ae Magna Ease\u2122 valve, Model 3300TFX, undergoing isolated aortic valve replacement."}], "periods": [{"title": "Overall Study", "milestones": [{"type": "STARTED", "achievements": [{"groupId": "FG000", "numSubjects": "283"}]}, {"type": "Subjects Implanted With Device", "achievements": [{"groupId": "FG000", "numSubjects": "258"}]}, {"type": "COMPLETED", "achievements": [{"groupId": "FG000", "numSubjects": "103"}]}, {"type": "NOT COMPLETED", "achievements": [{"groupId": "FG000", "numSubjects": "180"}]}], "dropWithdraws": [{"type": "On-Protocol", "reasons": [{"groupId": "FG000", "numSubjects": "67"}]}, {"type": "Death", "reasons": [{"groupId": "FG000", "numSubjects": "38"}]}, {"type": "Withdrawal by Subject", "reasons": [{"groupId": "FG000", "numSubjects": "31"}]}, {"type": "Explanted", "reasons": [{"groupId": "FG000", "numSubjects": "10"}]}, {"type": "Lost to Follow-up", "reasons": [{"groupId": "FG000", "numSubjects": "5"}]}, {"type": "Patient received valve-in-valve", "reasons": [{"groupId": "FG000", "numSubjects": "3"}]}, {"type": "Other", "reasons": [{"groupId": "FG000", "numSubjects": "1"}]}, {"type": "Consented but did not receive device", "reasons": [{"groupId": "FG000", "numSubjects": "25"}]}]}]}, "baselineCharacteristicsModule": {"populationDescription": "The outcome is reported for subjects who received the Carpentier-Edwards PERIMOUNT Magna Ease, Model 3300TFX, device where data is available.", "groups": [{"id": "BG000", "title": "Carpentier-Edwards\u00ae PERIMOUNT\u00ae Magna Ease\u2122, Model 3300TFX", "description": "Subjects who received the Carpentier-Edwards\u00ae PERIMOUNT\u00ae Magna Ease\u2122 valve, Model 3300TFX, undergoing isolated aortic valve replacement."}], "denoms": [{"units": "Participants", "counts": [{"groupId": "BG000", "value": "258"}]}], "measures": [{"title": "Age, Continuous", "paramType": "MEAN", "dispersionType": "STANDARD_DEVIATION", "unitOfMeasure": "years", "classes": [{"denoms": [{"units": "Participants", "counts": [{"groupId": "BG000", "value": "258"}]}], "categories": [{"measurements": [{"groupId": "BG000", "value": "68.5", "spread": "8.8"}]}]}]}, {"title": "Sex: Female, Male", "paramType": "COUNT_OF_PARTICIPANTS", "unitOfMeasure": "Participants", "classes": [{"denoms": [{"units": "Participants", "counts": [{"groupId": "BG000", "value": "258"}]}], "categories": [{"title": "Female", "measurements": [{"groupId": "BG000", "value": "91"}]}, {"title": "Male", "measurements": [{"groupId": "BG000", "value": "167"}]}]}]}, {"title": "Race and Ethnicity Not Collected", "populationDescription": "Race and Ethnicity were not collected from any participant.", "paramType": "COUNT_OF_PARTICIPANTS", "unitOfMeasure": "Participants", "classes": [{"denoms": [{"units": "Participants", "counts": [{"groupId": "BG000", "value": "0"}]}]}]}]}, "outcomeMeasuresModule": {"outcomeMeasures": [{"type": "PRIMARY", "title": "Subject's Percentage of Long Term Safety Performance", "description": "Long term safety performance will be evaluated by comparing the linearized yearly rates to the objective performance criteria (OPC) referenced in the Food and Drug Administration (FDA) 1994 Draft Heart Valve Guidance.\n\nExpressed as the Number of late events divided by the total number of late patient years times 100. Late patient years are calculated from 31 days post-implant to the date of the last contact (follow up or adverse event).", "populationDescription": "The outcome is reported for subjects who received the Carpentier-Edwards PERIMOUNT Magna Ease, Model 3300TFX, device where data is available.", "reportingStatus": "POSTED", "paramType": "NUMBER", "unitOfMeasure": "Percentage of events/late patient years", "timeFrame": "31 days through 8 years post-implant", "groups": [{"id": "OG000", "title": "Carpentier-Edwards\u00ae PERIMOUNT\u00ae Magna Ease\u2122, Model 3300TFX", "description": "Subjects who received the Carpentier-Edwards\u00ae PERIMOUNT\u00ae Magna Ease\u2122 valve, Model 3300TFX, undergoing isolated aortic valve replacement."}], "denoms": [{"units": "Participants", "counts": [{"groupId": "OG000", "value": "258"}]}], "classes": [{"title": "Thromboembolism", "categories": [{"measurements": [{"groupId": "OG000", "value": "1.5"}]}]}, {"title": "All Hemorrhage", "categories": [{"measurements": [{"groupId": "OG000", "value": "2.7"}]}]}, {"title": "All Perivalvular Leak", "categories": [{"measurements": [{"groupId": "OG000", "value": "0.2"}]}]}, {"title": "Endocarditis", "categories": [{"measurements": [{"groupId": "OG000", "value": "0.4"}]}]}]}, {"type": "PRIMARY", "title": "Number of Subject's in NYHA Functional Class I or II at 8 Year Post-Implant", "description": "The New York Heart Association (NYHA) functional classification system relates symptoms to everyday activities and the patient's quality of life.\n\nClass I. No limitation of physical activity. Ordinary physical activity does not cause undue fatigue, palpitation, dyspnea (shortness of breath).\n\nClass II. Slight limitation of physical activity. Comfortable at rest. Ordinary physical activity results in fatigue, palpitation, dyspnea (shortness of breath).", "populationDescription": "The outcome is reported for subjects who received the Carpentier-Edwards PERIMOUNT Magna Ease, Model 3300TFX, device where data is available.", "reportingStatus": "POSTED", "paramType": "COUNT_OF_PARTICIPANTS", "unitOfMeasure": "Participants", "timeFrame": "8 years post-implant", "groups": [{"id": "OG000", "title": "Carpentier-Edwards\u00ae PERIMOUNT\u00ae Magna Ease\u2122, Model 3300TFX", "description": "Subjects who received the Carpentier-Edwards\u00ae PERIMOUNT\u00ae Magna Ease\u2122 valve, Model 3300TFX, undergoing isolated aortic valve replacement."}], "denoms": [{"units": "Participants", "counts": [{"groupId": "OG000", "value": "98"}]}], "classes": [{"title": "Class I", "categories": [{"measurements": [{"groupId": "OG000", "value": "57"}]}]}, {"title": "Class II", "categories": [{"measurements": [{"groupId": "OG000", "value": "35"}]}]}]}, {"type": "PRIMARY", "title": "Subject's New York Heart Association (NYHA) Functional Class at 8 Years Post-Implant Compared to Baseline", "description": "The New York Heart Association (NYHA) functional classification system relates symptoms to everyday activities and the patient's quality of life.\n\nClass I. No limitation of physical activity. Ordinary physical activity does not cause undue fatigue, palpitation, dyspnea (shortness of breath).\n\nClass II. Slight limitation of physical activity. Comfortable at rest. Ordinary physical activity results in fatigue, palpitation, dyspnea (shortness of breath).\n\nClass III. Marked limitation of physical activity. Comfortable at rest. Less than ordinary activity causes fatigue, palpitation, or dyspnea.\n\nClass IV. Unable to carry on any physical activity without discomfort. Symptoms of heart failure at rest. If any physical activity is undertaken, discomfort increases.", "populationDescription": "The outcome is reported for subjects who received the Carpentier-Edwards PERIMOUNT Magna Ease, Model 3300TFX, device where data is available.", "reportingStatus": "POSTED", "paramType": "COUNT_OF_PARTICIPANTS", "unitOfMeasure": "Participants", "timeFrame": "8 Years post-implant", "groups": [{"id": "OG000", "title": "Carpentier-Edwards\u00ae PERIMOUNT\u00ae Magna Ease\u2122, Model 3300TFX", "description": "Subjects who received the Carpentier-Edwards\u00ae PERIMOUNT\u00ae Magna Ease\u2122 valve, Model 3300TFX, undergoing isolated aortic valve replacement."}], "denoms": [{"units": "Participants", "counts": [{"groupId": "OG000", "value": "97"}]}], "classes": [{"categories": [{"title": "Improve", "measurements": [{"groupId": "OG000", "value": "60"}]}, {"title": "Same", "measurements": [{"groupId": "OG000", "value": "31"}]}, {"title": "Worse", "measurements": [{"groupId": "OG000", "value": "6"}]}]}]}, {"type": "SECONDARY", "title": "Percent of Early Adverse Events", "description": "Number of early adverse events occurring within 30 days of procedure divided by the number of enrolled subjects times 100.", "populationDescription": "The outcome is reported for subjects who received the Carpentier-Edwards PERIMOUNT Magna Ease, Model 3300TFX, device where data is available.", "reportingStatus": "POSTED", "paramType": "NUMBER", "unitOfMeasure": "Percentage of Early Adverse Events", "timeFrame": "Events occurring within 30 days of procedure", "groups": [{"id": "OG000", "title": "Carpentier-Edwards\u00ae PERIMOUNT\u00ae Magna Ease\u2122, Model 3300TFX", "description": "Subjects who received the Carpentier-Edwards\u00ae PERIMOUNT\u00ae Magna Ease\u2122 valve, Model 3300TFX, undergoing isolated aortic valve replacement."}], "denoms": [{"units": "Participants", "counts": [{"groupId": "OG000", "value": "258"}]}], "classes": [{"title": "Bleeding Event", "categories": [{"measurements": [{"groupId": "OG000", "value": "6.2"}]}]}, {"title": "Major Bleeding Event", "categories": [{"measurements": [{"groupId": "OG000", "value": "5.0"}]}]}, {"title": "Thromboembolism", "categories": [{"measurements": [{"groupId": "OG000", "value": "1.9"}]}]}, {"title": "Endocarditis", "categories": [{"measurements": [{"groupId": "OG000", "value": "0.0"}]}]}, {"title": "Structural Valve Deterioration", "categories": [{"measurements": [{"groupId": "OG000", "value": "0.0"}]}]}, {"title": "Reoperation Due to SVD", "categories": [{"measurements": [{"groupId": "OG000", "value": "0.0"}]}]}, {"title": "Hemolysis", "categories": [{"measurements": [{"groupId": "OG000", "value": "0.0"}]}]}, {"title": "Non-Structural Valve Deterioration", "categories": [{"measurements": [{"groupId": "OG000", "value": "0.4"}]}]}, {"title": "Perivalvular Leak", "categories": [{"measurements": [{"groupId": "OG000", "value": "0.4"}]}]}, {"title": "Major Perivalvular Leak", "categories": [{"measurements": [{"groupId": "OG000", "value": "0.4"}]}]}, {"title": "Valve Thrombosis", "categories": [{"measurements": [{"groupId": "OG000", "value": "0.0"}]}]}, {"title": "Explant", "categories": [{"measurements": [{"groupId": "OG000", "value": "1.2"}]}]}, {"title": "Death", "categories": [{"measurements": [{"groupId": "OG000", "value": "0.4"}]}]}, {"title": "Valve-related death", "categories": [{"measurements": [{"groupId": "OG000", "value": "0.0"}]}]}]}, {"type": "SECONDARY", "title": "Percentage of Late Adverse Events", "description": "Number of late events divided by the total number of late patient years times 100. Late patient years are calculated from 31 days post-implant to the date of the last contact (follow up or adverse event).", "populationDescription": "The outcome is reported for subjects who received the Carpentier-Edwards PERIMOUNT Magna Ease, Model 3300TFX, device where data is available", "reportingStatus": "POSTED", "paramType": "NUMBER", "unitOfMeasure": "Percentage of events/late patient years", "timeFrame": "Events occurring >= 31 days and up through 8 years post-implant", "groups": [{"id": "OG000", "title": "Carpentier-Edwards\u00ae PERIMOUNT\u00ae Magna Ease\u2122, Model 3300TFX", "description": "Subjects who received the Carpentier-Edwards\u00ae PERIMOUNT\u00ae Magna Ease\u2122 valve, Model 3300TFX, undergoing isolated aortic valve replacement."}], "denoms": [{"units": "Participants", "counts": [{"groupId": "OG000", "value": "258"}]}], "classes": [{"title": "Bleeding Event", "categories": [{"measurements": [{"groupId": "OG000", "value": "2.7"}]}]}, {"title": "Major Bleeding Event", "categories": [{"measurements": [{"groupId": "OG000", "value": "1.3"}]}]}, {"title": "Thromboembolism", "categories": [{"measurements": [{"groupId": "OG000", "value": "1.5"}]}]}, {"title": "Endocarditis", "categories": [{"measurements": [{"groupId": "OG000", "value": "0.4"}]}]}, {"title": "Structural Valve Deterioration", "categories": [{"measurements": [{"groupId": "OG000", "value": "1.0"}]}]}, {"title": "Reoperation Due to SVD", "categories": [{"measurements": [{"groupId": "OG000", "value": "0.6"}]}]}, {"title": "Hemolysis", "categories": [{"measurements": [{"groupId": "OG000", "value": "0.1"}]}]}, {"title": "Non-Structural Valve Deterioration", "categories": [{"measurements": [{"groupId": "OG000", "value": "0.3"}]}]}, {"title": "Perivalvular Leak", "categories": [{"measurements": [{"groupId": "OG000", "value": "0.2"}]}]}, {"title": "Major Perivalvular Leak", "categories": [{"measurements": [{"groupId": "OG000", "value": "0.1"}]}]}, {"title": "Valve Thrombosis", "categories": [{"measurements": [{"groupId": "OG000", "value": "0.0"}]}]}, {"title": "Explant", "categories": [{"measurements": [{"groupId": "OG000", "value": "0.5"}]}]}, {"title": "Death", "categories": [{"measurements": [{"groupId": "OG000", "value": "2.3"}]}]}, {"title": "Valve-related death", "categories": [{"measurements": [{"groupId": "OG000", "value": "0.5"}]}]}]}, {"type": "SECONDARY", "title": "Percent of Subjects With Freedom From Serious Adverse Events (SAE) Post-implant > 30 Days", "description": "Subject's freedom from Serious Adverse Events at \\> 30 days post-implant. Time to events were estimated by Kaplan-Meier method.", "populationDescription": "The outcome is reported for subjects who received the Carpentier-Edwards PERIMOUNT Magna Ease, Model 3300TFX, device where data is available.", "reportingStatus": "POSTED", "paramType": "NUMBER", "dispersionType": "95% Confidence Interval", "unitOfMeasure": "percentage of subjects", "timeFrame": "1 Year, 2 Years, 3 Years, 4 Years, 5 Years, 6 Years, 7 Years, and 8 Years post-implant", "groups": [{"id": "OG000", "title": "Magna Ease\u2122, Model 3300TFX - 1 Year Post-Implant", "description": "Subjects who received the Carpentier-Edwards\u00ae PERIMOUNT\u00ae Magna Ease\u2122 valve, Model 3300TFX, undergoing isolated aortic valve replacement."}, {"id": "OG001", "title": "Magna Ease\u2122, Model 3300TFX - 2 Year Post-Implant", "description": "Subjects who received the Carpentier-Edwards\u00ae PERIMOUNT\u00ae Magna Ease\u2122 valve, Model 3300TFX, undergoing isolated aortic valve replacement."}, {"id": "OG002", "title": "Magna Ease\u2122, Model 3300TFX - 3 Year Post-Implant", "description": "Subjects who received the Carpentier-Edwards\u00ae PERIMOUNT\u00ae Magna Ease\u2122 valve, Model 3300TFX, undergoing isolated aortic valve replacement."}, {"id": "OG003", "title": "Magna Ease\u2122, Model 3300TFX - 4 Year Post-Implant", "description": "Subjects who received the Carpentier-Edwards\u00ae PERIMOUNT\u00ae Magna Ease\u2122 valve, Model 3300TFX, undergoing isolated aortic valve replacement."}, {"id": "OG004", "title": "Magna Ease\u2122, Model 3300TFX - 5 Year Post-Implant", "description": "Subjects who received the Carpentier-Edwards\u00ae PERIMOUNT\u00ae Magna Ease\u2122 valve, Model 3300TFX, undergoing isolated aortic valve replacement."}, {"id": "OG005", "title": "Magna Ease\u2122, Model 3300TFX - 6 Year Post-Implant", "description": "Subjects who received the Carpentier-Edwards\u00ae PERIMOUNT\u00ae Magna Ease\u2122 valve, Model 3300TFX, undergoing isolated aortic valve replacement."}, {"id": "OG006", "title": "Magna Ease\u2122, Model 3300TFX - 7 Year Post-Implant", "description": "Subjects who received the Carpentier-Edwards\u00ae PERIMOUNT\u00ae Magna Ease\u2122 valve, Model 3300TFX, undergoing isolated aortic valve replacement."}, {"id": "OG007", "title": "Magna Ease\u2122, Model 3300TFX - 8 Year Post-Implant", "description": "Subjects who received the Carpentier-Edwards\u00ae PERIMOUNT\u00ae Magna Ease\u2122 valve, Model 3300TFX, undergoing isolated aortic valve replacement."}], "denoms": [{"units": "Participants", "counts": [{"groupId": "OG000", "value": "258"}, {"groupId": "OG001", "value": "258"}, {"groupId": "OG002", "value": "258"}, {"groupId": "OG003", "value": "258"}, {"groupId": "OG004", "value": "258"}, {"groupId": "OG005", "value": "258"}, {"groupId": "OG006", "value": "258"}, {"groupId": "OG007", "value": "258"}]}], "classes": [{"title": "Death", "categories": [{"measurements": [{"groupId": "OG000", "value": "97.60", "lowerLimit": "95.71", "upperLimit": "99.50"}, {"groupId": "OG001", "value": "97.19", "lowerLimit": "95.14", "upperLimit": "99.24"}, {"groupId": "OG002", "value": "95.50", "lowerLimit": "92.89", "upperLimit": "98.10"}, {"groupId": "OG003", "value": "93.76", "lowerLimit": "90.70", "upperLimit": "96.82"}, {"groupId": "OG004", "value": "91.54", "lowerLimit": "87.98", "upperLimit": "95.09"}, {"groupId": "OG005", "value": "89.20", "lowerLimit": "85.18", "upperLimit": "93.21"}, {"groupId": "OG006", "value": "85.16", "lowerLimit": "80.34", "upperLimit": "89.98"}, {"groupId": "OG007", "value": "80.69", "lowerLimit": "74.94", "upperLimit": "86.43"}]}]}, {"title": "Valve-related death", "categories": [{"measurements": [{"groupId": "OG000", "value": "99.60", "lowerLimit": "98.83", "upperLimit": "100.0"}, {"groupId": "OG001", "value": "99.60", "lowerLimit": "98.83", "upperLimit": "100.0"}, {"groupId": "OG002", "value": "98.74", "lowerLimit": "97.32", "upperLimit": "100.0"}, {"groupId": "OG003", "value": "98.28", "lowerLimit": "96.61", "upperLimit": "99.95"}, {"groupId": "OG004", "value": "97.81", "lowerLimit": "95.91", "upperLimit": "99.71"}, {"groupId": "OG005", "value": "97.31", "lowerLimit": "95.18", "upperLimit": "99.44"}, {"groupId": "OG006", "value": "96.66", "lowerLimit": "94.19", "upperLimit": "99.13"}, {"groupId": "OG007", "value": "95.79", "lowerLimit": "92.81", "upperLimit": "98.77"}]}]}, {"title": "Reoperation", "categories": [{"measurements": [{"groupId": "OG000", "value": "97.63", "lowerLimit": "95.76", "upperLimit": "99.51"}, {"groupId": "OG001", "value": "97.21", "lowerLimit": "95.18", "upperLimit": "99.25"}, {"groupId": "OG002", "value": "96.78", "lowerLimit": "94.59", "upperLimit": "98.98"}, {"groupId": "OG003", "value": "95.89", "lowerLimit": "93.39", "upperLimit": "98.39"}, {"groupId": "OG004", "value": "95.89", "lowerLimit": "93.39", "upperLimit": "98.39"}, {"groupId": "OG005", "value": "95.37", "lowerLimit": "92.69", "upperLimit": "98.06"}, {"groupId": "OG006", "value": "94.07", "lowerLimit": "90.87", "upperLimit": "97.27"}, {"groupId": "OG007", "value": "89.83", "lowerLimit": "85.09", "upperLimit": "94.58"}]}]}, {"title": "Explant", "categories": [{"measurements": [{"groupId": "OG000", "value": "98.04", "lowerLimit": "96.34", "upperLimit": "99.74"}, {"groupId": "OG001", "value": "97.62", "lowerLimit": "95.74", "upperLimit": "99.50"}, {"groupId": "OG002", "value": "97.19", "lowerLimit": "95.14", "upperLimit": "99.25"}, {"groupId": "OG003", "value": "96.30", "lowerLimit": "93.92", "upperLimit": "98.68"}, {"groupId": "OG004", "value": "96.30", "lowerLimit": "93.92", "upperLimit": "98.68"}, {"groupId": "OG005", "value": "96.30", "lowerLimit": "93.92", "upperLimit": "98.68"}, {"groupId": "OG006", "value": "95.65", "lowerLimit": "92.96", "upperLimit": "98.33"}, {"groupId": "OG007", "value": "94.81", "lowerLimit": "91.70", "upperLimit": "97.93"}]}]}, {"title": "Bleeding Event", "categories": [{"measurements": [{"groupId": "OG000", "value": "88.44", "lowerLimit": "84.48", "upperLimit": "92.40"}, {"groupId": "OG001", "value": "86.76", "lowerLimit": "82.55", "upperLimit": "90.98"}, {"groupId": "OG002", "value": "84.13", "lowerLimit": "79.55", "upperLimit": "88.71"}, {"groupId": "OG003", "value": "83.22", "lowerLimit": "78.51", "upperLimit": "87.92"}, {"groupId": "OG004", "value": "81.79", "lowerLimit": "76.90", "upperLimit": "86.69"}, {"groupId": "OG005", "value": "81.29", "lowerLimit": "76.33", "upperLimit": "86.25"}, {"groupId": "OG006", "value": "80.63", "lowerLimit": "75.54", "upperLimit": "85.72"}, {"groupId": "OG007", "value": "77.95", "lowerLimit": "72.20", "upperLimit": "83.70"}]}]}, {"title": "Major Bleeding Event", "categories": [{"measurements": [{"groupId": "OG000", "value": "92.51", "lowerLimit": "89.26", "upperLimit": "95.75"}, {"groupId": "OG001", "value": "92.09", "lowerLimit": "88.75", "upperLimit": "95.42"}, {"groupId": "OG002", "value": "90.33", "lowerLimit": "86.64", "upperLimit": "94.02"}, {"groupId": "OG003", "value": "90.33", "lowerLimit": "86.64", "upperLimit": "94.02"}, {"groupId": "OG004", "value": "88.91", "lowerLimit": "84.95", "upperLimit": "92.87"}, {"groupId": "OG005", "value": "88.40", "lowerLimit": "84.34", "upperLimit": "92.47"}, {"groupId": "OG006", "value": "87.75", "lowerLimit": "83.52", "upperLimit": "91.98"}, {"groupId": "OG007", "value": "85.08", "lowerLimit": "80.02", "upperLimit": "90.15"}]}]}, {"title": "Thromboembolism", "categories": [{"measurements": [{"groupId": "OG000", "value": "96.03", "lowerLimit": "93.61", "upperLimit": "98.44"}, {"groupId": "OG001", "value": "94.32", "lowerLimit": "91.43", "upperLimit": "97.22"}, {"groupId": "OG002", "value": "92.56", "lowerLimit": "89.25", "upperLimit": "95.88"}, {"groupId": "OG003", "value": "92.11", "lowerLimit": "88.69", "upperLimit": "95.52"}, {"groupId": "OG004", "value": "90.70", "lowerLimit": "86.98", "upperLimit": "94.41"}, {"groupId": "OG005", "value": "89.68", "lowerLimit": "85.75", "upperLimit": "93.62"}, {"groupId": "OG006", "value": "88.39", "lowerLimit": "84.13", "upperLimit": "92.66"}, {"groupId": "OG007", "value": "86.68", "lowerLimit": "81.88", "upperLimit": "91.47"}]}]}, {"title": "Endocarditis", "categories": [{"measurements": [{"groupId": "OG000", "value": "98.81", "lowerLimit": "97.47", "upperLimit": "100.0"}, {"groupId": "OG001", "value": "98.39", "lowerLimit": "96.83", "upperLimit": "99.96"}, {"groupId": "OG002", "value": "98.39", "lowerLimit": "96.83", "upperLimit": "99.96"}, {"groupId": "OG003", "value": "97.94", "lowerLimit": "96.15", "upperLimit": "99.73"}, {"groupId": "OG004", "value": "97.94", "lowerLimit": "96.15", "upperLimit": "99.73"}, {"groupId": "OG005", "value": "97.94", "lowerLimit": "96.15", "upperLimit": "99.73"}, {"groupId": "OG006", "value": "97.27", "lowerLimit": "95.07", "upperLimit": "99.48"}, {"groupId": "OG007", "value": "97.27", "lowerLimit": "95.07", "upperLimit": "99.48"}]}]}, {"title": "Perivalvular leak", "categories": [{"measurements": [{"groupId": "OG000", "value": "98.78", "lowerLimit": "97.41", "upperLimit": "100.0"}, {"groupId": "OG001", "value": "98.36", "lowerLimit": "96.77", "upperLimit": "99.95"}, {"groupId": "OG002", "value": "98.36", "lowerLimit": "96.77", "upperLimit": "99.95"}, {"groupId": "OG003", "value": "98.36", "lowerLimit": "96.77", "upperLimit": "99.95"}, {"groupId": "OG004", "value": "98.36", "lowerLimit": "96.77", "upperLimit": "99.95"}, {"groupId": "OG005", "value": "98.36", "lowerLimit": "96.77", "upperLimit": "99.95"}, {"groupId": "OG006", "value": "98.36", "lowerLimit": "96.77", "upperLimit": "99.95"}, {"groupId": "OG007", "value": "98.36", "lowerLimit": "96.77", "upperLimit": "99.95"}]}]}, {"title": "Major perivalvular leak", "categories": [{"measurements": [{"groupId": "OG000", "value": "99.20", "lowerLimit": "98.09", "upperLimit": "100.0"}, {"groupId": "OG001", "value": "99.20", "lowerLimit": "98.09", "upperLimit": "100.0"}, {"groupId": "OG002", "value": "99.20", "lowerLimit": "98.09", "upperLimit": "100.0"}, {"groupId": "OG003", "value": "99.20", "lowerLimit": "98.09", "upperLimit": "100.0"}, {"groupId": "OG004", "value": "99.20", "lowerLimit": "98.09", "upperLimit": "100.0"}, {"groupId": "OG005", "value": "99.20", "lowerLimit": "98.09", "upperLimit": "100.0"}, {"groupId": "OG006", "value": "99.20", "lowerLimit": "98.09", "upperLimit": "100.0"}, {"groupId": "OG007", "value": "99.20", "lowerLimit": "98.09", "upperLimit": "100.0"}]}]}, {"title": "Hemolysis", "categories": [{"measurements": [{"groupId": "OG000", "value": "99.18", "lowerLimit": "98.04", "upperLimit": "100.0"}, {"groupId": "OG001", "value": "99.18", "lowerLimit": "98.04", "upperLimit": "100.0"}, {"groupId": "OG002", "value": "99.18", "lowerLimit": "98.04", "upperLimit": "100.0"}, {"groupId": "OG003", "value": "99.18", "lowerLimit": "98.04", "upperLimit": "100.0"}, {"groupId": "OG004", "value": "99.18", "lowerLimit": "98.04", "upperLimit": "100.0"}, {"groupId": "OG005", "value": "99.18", "lowerLimit": "98.04", "upperLimit": "100.0"}, {"groupId": "OG006", "value": "99.18", "lowerLimit": "98.04", "upperLimit": "100.0"}, {"groupId": "OG007", "value": "99.18", "lowerLimit": "98.04", "upperLimit": "100.0"}]}]}, {"title": "Non-structural valve dysfunction", "categories": [{"measurements": [{"groupId": "OG000", "value": "98.78", "lowerLimit": "97.41", "upperLimit": "100.0"}, {"groupId": "OG001", "value": "98.36", "lowerLimit": "96.77", "upperLimit": "99.95"}, {"groupId": "OG002", "value": "98.36", "lowerLimit": "96.77", "upperLimit": "99.95"}, {"groupId": "OG003", "value": "97.91", "lowerLimit": "96.09", "upperLimit": "99.73"}, {"groupId": "OG004", "value": "97.91", "lowerLimit": "96.09", "upperLimit": "99.73"}, {"groupId": "OG005", "value": "97.91", "lowerLimit": "96.09", "upperLimit": "99.73"}, {"groupId": "OG006", "value": "97.91", "lowerLimit": "96.09", "upperLimit": "99.73"}, {"groupId": "OG007", "value": "97.91", "lowerLimit": "96.09", "upperLimit": "99.73"}]}]}, {"title": "Structural valve deterioration", "categories": [{"measurements": [{"groupId": "OG000", "value": "100.0", "lowerLimit": "100.0", "upperLimit": "100.0"}, {"groupId": "OG001", "value": "99.57", "lowerLimit": "98.74", "upperLimit": "100.0"}, {"groupId": "OG002", "value": "99.13", "lowerLimit": "97.94", "upperLimit": "100.0"}, {"groupId": "OG003", "value": "99.13", "lowerLimit": "97.94", "upperLimit": "100.0"}, {"groupId": "OG004", "value": "99.13", "lowerLimit": "97.94", "upperLimit": "100.0"}, {"groupId": "OG005", "value": "97.07", "lowerLimit": "94.75", "upperLimit": "99.39"}, {"groupId": "OG006", "value": "95.74", "lowerLimit": "92.81", "upperLimit": "98.67"}, {"groupId": "OG007", "value": "90.08", "lowerLimit": "84.74", "upperLimit": "95.42"}]}]}, {"title": "Valve thrombosis", "categories": [{"measurements": [{"groupId": "OG000", "value": "100.0", "lowerLimit": "100.0", "upperLimit": "100.0"}, {"groupId": "OG001", "value": "100.0", "lowerLimit": "100.0", "upperLimit": "100.0"}, {"groupId": "OG002", "value": "100.0", "lowerLimit": "100.0", "upperLimit": "100.0"}, {"groupId": "OG003", "value": "100.0", "lowerLimit": "100.0", "upperLimit": "100.0"}, {"groupId": "OG004", "value": "100.0", "lowerLimit": "100.0", "upperLimit": "100.0"}, {"groupId": "OG005", "value": "100.0", "lowerLimit": "100.0", "upperLimit": "100.0"}, {"groupId": "OG006", "value": "100.0", "lowerLimit": "100.0", "upperLimit": "100.0"}, {"groupId": "OG007", "value": "100.0", "lowerLimit": "100.0", "upperLimit": "100.0"}]}]}]}, {"type": "SECONDARY", "title": "Subject's Average Peak Systolic Gradient (mmHg) Measurements at 8 Years Post-implant", "description": "Peak systolic gradient is the maximum value measured of flow of blood through the aortic valve as measured in millimeters of mercury. The data summary will be stratified by valve size.", "populationDescription": "The outcome is reported for subjects who received the Carpentier-Edwards PERIMOUNT Magna Ease, Model 3300TFX, device where data is available.", "reportingStatus": "POSTED", "paramType": "MEAN", "dispersionType": "Standard Deviation", "unitOfMeasure": "mmHg", "timeFrame": "8 years post-implant", "groups": [{"id": "OG000", "title": "Carpentier-Edwards\u00ae PERIMOUNT\u00ae Magna Ease\u2122, Model 3300TFX", "description": "Subjects who received the Carpentier-Edwards\u00ae PERIMOUNT\u00ae Magna Ease\u2122 valve, Model 3300TFX, undergoing isolated aortic valve replacement."}], "denoms": [{"units": "Participants", "counts": [{"groupId": "OG000", "value": "89"}]}], "classes": [{"title": "19 mm", "denoms": [{"units": "Participants", "counts": [{"groupId": "OG000", "value": "4"}]}], "categories": [{"measurements": [{"groupId": "OG000", "value": "24.6", "spread": "17.94"}]}]}, {"title": "21 mm", "denoms": [{"units": "Participants", "counts": [{"groupId": "OG000", "value": "11"}]}], "categories": [{"measurements": [{"groupId": "OG000", "value": "24.7", "spread": "23.52"}]}]}, {"title": "23 mm", "denoms": [{"units": "Participants", "counts": [{"groupId": "OG000", "value": "33"}]}], "categories": [{"measurements": [{"groupId": "OG000", "value": "26.3", "spread": "21.41"}]}]}, {"title": "25 mm", "denoms": [{"units": "Participants", "counts": [{"groupId": "OG000", "value": "35"}]}], "categories": [{"measurements": [{"groupId": "OG000", "value": "21.6", "spread": "8.94"}]}]}, {"title": "27 mm", "denoms": [{"units": "Participants", "counts": [{"groupId": "OG000", "value": "4"}]}], "categories": [{"measurements": [{"groupId": "OG000", "value": "22.1", "spread": "8.81"}]}]}, {"title": "29 mm", "denoms": [{"units": "Participants", "counts": [{"groupId": "OG000", "value": "2"}]}], "categories": [{"measurements": [{"groupId": "OG000", "value": "23.1", "spread": "15.41"}]}]}]}, {"type": "SECONDARY", "title": "Subject's Average Mean Systolic Gradient (mmHg) Measurements at 8 Years Post-implant.", "description": "Mean systolic gradient is the average flow of blood through the aortic valve measured in millimeters of mercury. Mean gradient values depend on the size and type of valve. The data summary will be stratified by valve size.", "populationDescription": "The outcome is reported for subjects who received the Carpentier-Edwards PERIMOUNT Magna Ease, Model 3300TFX, device where data is available.", "reportingStatus": "POSTED", "paramType": "MEAN", "dispersionType": "Standard Deviation", "unitOfMeasure": "mmHg", "timeFrame": "8 years post-implant", "groups": [{"id": "OG000", "title": "Carpentier-Edwards\u00ae PERIMOUNT\u00ae Magna Ease\u2122, Model 3300TFX", "description": "Subjects who received the Carpentier-Edwards\u00ae PERIMOUNT\u00ae Magna Ease\u2122 valve, Model 3300TFX, undergoing isolated aortic valve replacement."}], "denoms": [{"units": "Participants", "counts": [{"groupId": "OG000", "value": "89"}]}], "classes": [{"title": "19 mm", "denoms": [{"units": "Participants", "counts": [{"groupId": "OG000", "value": "4"}]}], "categories": [{"measurements": [{"groupId": "OG000", "value": "17.7", "spread": "6.38"}]}]}, {"title": "21 mm", "denoms": [{"units": "Participants", "counts": [{"groupId": "OG000", "value": "11"}]}], "categories": [{"measurements": [{"groupId": "OG000", "value": "17.2", "spread": "10.82"}]}]}, {"title": "23 mm", "denoms": [{"units": "Participants", "counts": [{"groupId": "OG000", "value": "33"}]}], "categories": [{"measurements": [{"groupId": "OG000", "value": "16.2", "spread": "10.46"}]}]}, {"title": "25 mm", "denoms": [{"units": "Participants", "counts": [{"groupId": "OG000", "value": "35"}]}], "categories": [{"measurements": [{"groupId": "OG000", "value": "12.7", "spread": "4.56"}]}]}, {"title": "27 mm", "denoms": [{"units": "Participants", "counts": [{"groupId": "OG000", "value": "4"}]}], "categories": [{"measurements": [{"groupId": "OG000", "value": "12.2", "spread": "4.51"}]}]}, {"title": "29 mm", "denoms": [{"units": "Participants", "counts": [{"groupId": "OG000", "value": "2"}]}], "categories": [{"measurements": [{"groupId": "OG000", "value": "13.3", "spread": "9.48"}]}]}]}, {"type": "SECONDARY", "title": "Subject's Average Effective Orifice Area Measurements at 8 Years Post-implant.", "description": "Effective orifice area represents the cross-sectional area of the blood flow downstream of the aortic valve. The data summary will be stratified by valve size.", "populationDescription": "The outcome is reported for subjects who received the Carpentier-Edwards PERIMOUNT Magna Ease, Model 3300TFX, device where data is available.", "reportingStatus": "POSTED", "paramType": "MEAN", "dispersionType": "Standard Deviation", "unitOfMeasure": "Centimeters Squared", "timeFrame": "8 years post-implant", "groups": [{"id": "OG000", "title": "Carpentier-Edwards\u00ae PERIMOUNT\u00ae Magna Ease\u2122, Model 3300TFX", "description": "Subjects who received the Carpentier-Edwards\u00ae PERIMOUNT\u00ae Magna Ease\u2122 valve, Model 3300TFX, undergoing isolated aortic valve replacement."}], "denoms": [{"units": "Participants", "counts": [{"groupId": "OG000", "value": "86"}]}], "classes": [{"title": "19 mm", "denoms": [{"units": "Participants", "counts": [{"groupId": "OG000", "value": "3"}]}], "categories": [{"measurements": [{"groupId": "OG000", "value": "1.0", "spread": "0.15"}]}]}, {"title": "21 mm", "denoms": [{"units": "Participants", "counts": [{"groupId": "OG000", "value": "11"}]}], "categories": [{"measurements": [{"groupId": "OG000", "value": "1.4", "spread": "0.40"}]}]}, {"title": "23 mm", "denoms": [{"units": "Participants", "counts": [{"groupId": "OG000", "value": "33"}]}], "categories": [{"measurements": [{"groupId": "OG000", "value": "1.4", "spread": "0.53"}]}]}, {"title": "25 mm", "denoms": [{"units": "Participants", "counts": [{"groupId": "OG000", "value": "34"}]}], "categories": [{"measurements": [{"groupId": "OG000", "value": "1.7", "spread": "0.47"}]}]}, {"title": "27 mm", "denoms": [{"units": "Participants", "counts": [{"groupId": "OG000", "value": "3"}]}], "categories": [{"measurements": [{"groupId": "OG000", "value": "2.1", "spread": "0.32"}]}]}, {"title": "29 mm", "denoms": [{"units": "Participants", "counts": [{"groupId": "OG000", "value": "2"}]}], "categories": [{"measurements": [{"groupId": "OG000", "value": "1.9", "spread": "0.44"}]}]}]}, {"type": "SECONDARY", "title": "Subject's Average Effective Orifice Area Index (EOAI) Measurements at 8 Years Post-implant.", "description": "Effective orifice area index represents the minimal cross-sectional area of the blood flow downstream of the aortic valve divided by the person's body surface area. The data summary will be stratified by valve size.", "populationDescription": "The outcome is reported for subjects who received the Carpentier-Edwards PERIMOUNT Magna Ease, Model 3300TFX, device where data is available.", "reportingStatus": "POSTED", "paramType": "MEAN", "dispersionType": "Standard Deviation", "unitOfMeasure": "centimeters squared/meters squared", "timeFrame": "8 years post-implant", "groups": [{"id": "OG000", "title": "Carpentier-Edwards\u00ae PERIMOUNT\u00ae Magna Ease\u2122, Model 3300TFX", "description": "Subjects who received the Carpentier-Edwards\u00ae PERIMOUNT\u00ae Magna Ease\u2122 valve, Model 3300TFX, undergoing isolated aortic valve replacement."}], "denoms": [{"units": "Participants", "counts": [{"groupId": "OG000", "value": "86"}]}], "classes": [{"title": "19 mm", "denoms": [{"units": "Participants", "counts": [{"groupId": "OG000", "value": "3"}]}], "categories": [{"measurements": [{"groupId": "OG000", "value": "0.6", "spread": "0.11"}]}]}, {"title": "21 mm", "denoms": [{"units": "Participants", "counts": [{"groupId": "OG000", "value": "11"}]}], "categories": [{"measurements": [{"groupId": "OG000", "value": "0.7", "spread": "0.20"}]}]}, {"title": "23 mm", "denoms": [{"units": "Participants", "counts": [{"groupId": "OG000", "value": "33"}]}], "categories": [{"measurements": [{"groupId": "OG000", "value": "0.8", "spread": "0.32"}]}]}, {"title": "25 mm", "denoms": [{"units": "Participants", "counts": [{"groupId": "OG000", "value": "34"}]}], "categories": [{"measurements": [{"groupId": "OG000", "value": "0.8", "spread": "0.21"}]}]}, {"title": "27 mm", "denoms": [{"units": "Participants", "counts": [{"groupId": "OG000", "value": "3"}]}], "categories": [{"measurements": [{"groupId": "OG000", "value": "1.1", "spread": "0.10"}]}]}, {"title": "29 mm", "denoms": [{"units": "Participants", "counts": [{"groupId": "OG000", "value": "2"}]}], "categories": [{"measurements": [{"groupId": "OG000", "value": "0.9", "spread": "0.24"}]}]}]}, {"type": "SECONDARY", "title": "Subject's Average Performance Index Measurements at 8 Years Post-implant.", "description": "Performance index is defined as the subject's effective orifice area (the cross-sectional area of the blood flow downstream of the aortic valve) divided by the subject's native orifice area. The data summary will be stratified by valve size.", "populationDescription": "The outcome is reported for subjects who received the Carpentier-Edwards PERIMOUNT Magna Ease, Model 3300TFX, device where data is available.", "reportingStatus": "POSTED", "paramType": "MEAN", "dispersionType": "Standard Deviation", "unitOfMeasure": "cm^2/cm^2", "timeFrame": "8 years post-implant", "groups": [{"id": "OG000", "title": "Carpentier-Edwards\u00ae PERIMOUNT\u00ae Magna Ease\u2122, Model 3300TFX", "description": "Subjects who received the Carpentier-Edwards\u00ae PERIMOUNT\u00ae Magna Ease\u2122 valve, Model 3300TFX, undergoing isolated aortic valve replacement."}], "denoms": [{"units": "Participants", "counts": [{"groupId": "OG000", "value": "86"}]}], "classes": [{"title": "19 mm", "denoms": [{"units": "Participants", "counts": [{"groupId": "OG000", "value": "3"}]}], "categories": [{"measurements": [{"groupId": "OG000", "value": "0.5", "spread": "0.09"}]}]}, {"title": "21 mm", "denoms": [{"units": "Participants", "counts": [{"groupId": "OG000", "value": "11"}]}], "categories": [{"measurements": [{"groupId": "OG000", "value": "0.5", "spread": "0.14"}]}]}, {"title": "23 mm", "denoms": [{"units": "Participants", "counts": [{"groupId": "OG000", "value": "33"}]}], "categories": [{"measurements": [{"groupId": "OG000", "value": "0.4", "spread": "0.18"}]}]}, {"title": "25 mm", "denoms": [{"units": "Participants", "counts": [{"groupId": "OG000", "value": "34"}]}], "categories": [{"measurements": [{"groupId": "OG000", "value": "0.4", "spread": "0.10"}]}]}, {"title": "27 mm", "denoms": [{"units": "Participants", "counts": [{"groupId": "OG000", "value": "3"}]}], "categories": [{"measurements": [{"groupId": "OG000", "value": "0.4", "spread": "0.04"}]}]}, {"title": "29 mm", "denoms": [{"units": "Participants", "counts": [{"groupId": "OG000", "value": "2"}]}], "categories": [{"measurements": [{"groupId": "OG000", "value": "0.3", "spread": "0.09"}]}]}]}, {"type": "SECONDARY", "title": "Subject's Average Cardiac Output Measurements at 8 Years Post-implant.", "description": "The amount of blood the heart pumps through the circulatory system in a minute. The data summary will be stratified by valve size.", "populationDescription": "The outcome is reported for subjects who received the Carpentier-Edwards PERIMOUNT Magna Ease, Model 3300TFX, device where data is available.", "reportingStatus": "POSTED", "paramType": "MEAN", "dispersionType": "Standard Deviation", "unitOfMeasure": "Liters per minute", "timeFrame": "8 years post-implant", "groups": [{"id": "OG000", "title": "Carpentier-Edwards\u00ae PERIMOUNT\u00ae Magna Ease\u2122, Model 3300TFX", "description": "Subjects who received the Carpentier-Edwards\u00ae PERIMOUNT\u00ae Magna Ease\u2122 valve, Model 3300TFX, undergoing isolated aortic valve replacement."}], "denoms": [{"units": "Participants", "counts": [{"groupId": "OG000", "value": "86"}]}], "classes": [{"title": "19 mm", "denoms": [{"units": "Participants", "counts": [{"groupId": "OG000", "value": "3"}]}], "categories": [{"measurements": [{"groupId": "OG000", "value": "3.6", "spread": "0.32"}]}]}, {"title": "21 mm", "denoms": [{"units": "Participants", "counts": [{"groupId": "OG000", "value": "11"}]}], "categories": [{"measurements": [{"groupId": "OG000", "value": "5.2", "spread": "1.23"}]}]}, {"title": "23 mm", "denoms": [{"units": "Participants", "counts": [{"groupId": "OG000", "value": "33"}]}], "categories": [{"measurements": [{"groupId": "OG000", "value": "5.0", "spread": "1.10"}]}]}, {"title": "25 mm", "denoms": [{"units": "Participants", "counts": [{"groupId": "OG000", "value": "34"}]}], "categories": [{"measurements": [{"groupId": "OG000", "value": "5.1", "spread": "1.28"}]}]}, {"title": "27 mm", "denoms": [{"units": "Participants", "counts": [{"groupId": "OG000", "value": "3"}]}], "categories": [{"measurements": [{"groupId": "OG000", "value": "6.3", "spread": "2.10"}]}]}, {"title": "29 mm", "denoms": [{"units": "Participants", "counts": [{"groupId": "OG000", "value": "2"}]}], "categories": [{"measurements": [{"groupId": "OG000", "value": "5.3", "spread": "0.78"}]}]}]}, {"type": "SECONDARY", "title": "Subject's Average Cardiac Index Measurements at 8 Years Post-implant.", "description": "Cardiac index is an assessment that divides the cardiac output from left ventricle in one minute by the person's body surface area (BSA), thus relating heart performance to the size of the individual. The data summary will be stratified by valve size.", "populationDescription": "The outcome is reported for subjects who received the Carpentier-Edwards PERIMOUNT Magna Ease, Model 3300TFX, device where data is available.", "reportingStatus": "POSTED", "paramType": "MEAN", "dispersionType": "Standard Deviation", "unitOfMeasure": "L/min/m^2", "timeFrame": "8 years post-implant", "groups": [{"id": "OG000", "title": "Carpentier-Edwards\u00ae PERIMOUNT\u00ae Magna Ease\u2122, Model 3300TFX", "description": "Subjects who received the Carpentier-Edwards\u00ae PERIMOUNT\u00ae Magna Ease\u2122 valve, Model 3300TFX, undergoing isolated aortic valve replacement."}], "denoms": [{"units": "Participants", "counts": [{"groupId": "OG000", "value": "86"}]}], "classes": [{"title": "19 mm", "denoms": [{"units": "Participants", "counts": [{"groupId": "OG000", "value": "3"}]}], "categories": [{"measurements": [{"groupId": "OG000", "value": "2.3", "spread": "0.22"}]}]}, {"title": "21 mm", "denoms": [{"units": "Participants", "counts": [{"groupId": "OG000", "value": "11"}]}], "categories": [{"measurements": [{"groupId": "OG000", "value": "2.9", "spread": "0.55"}]}]}, {"title": "23 mm", "denoms": [{"units": "Participants", "counts": [{"groupId": "OG000", "value": "33"}]}], "categories": [{"measurements": [{"groupId": "OG000", "value": "2.7", "spread": "0.60"}]}]}, {"title": "25 mm", "denoms": [{"units": "Participants", "counts": [{"groupId": "OG000", "value": "34"}]}], "categories": [{"measurements": [{"groupId": "OG000", "value": "2.6", "spread": "0.60"}]}]}, {"title": "27 mm", "denoms": [{"units": "Participants", "counts": [{"groupId": "OG000", "value": "3"}]}], "categories": [{"measurements": [{"groupId": "OG000", "value": "3.1", "spread": "0.91"}]}]}, {"title": "29 mm", "denoms": [{"units": "Participants", "counts": [{"groupId": "OG000", "value": "2"}]}], "categories": [{"measurements": [{"groupId": "OG000", "value": "2.6", "spread": "0.32"}]}]}]}, {"type": "SECONDARY", "title": "Subject's Amount of Aortic Valvular Regurgitation at 8 Years Post-Implant.", "description": "Aortic valvular regurgitation occurs when the aortic valve in the heart does not close tightly allowing some of the blood that was pumped out of the heart to leak back into it. Aortic valvular regurgitation is evaluated by echocardiography over time. It is assessed on a scale from 0 to 4, where 0 represents no regurgitation and 4 represents severe regurgitation.", "populationDescription": "The outcome is reported for subjects who received the Carpentier-Edwards PERIMOUNT Magna Ease, Model 3300TFX, device where data is available.", "reportingStatus": "POSTED", "paramType": "COUNT_OF_PARTICIPANTS", "unitOfMeasure": "Participants", "timeFrame": "8 years post-implant", "groups": [{"id": "OG000", "title": "Carpentier-Edwards\u00ae PERIMOUNT\u00ae Magna Ease\u2122, Model 3300TFX", "description": "Subjects who received the Carpentier-Edwards\u00ae PERIMOUNT\u00ae Magna Ease\u2122 valve, Model 3300TFX, undergoing isolated aortic valve replacement."}], "denoms": [{"units": "Participants", "counts": [{"groupId": "OG000", "value": "88"}]}], "classes": [{"title": "0 None", "categories": [{"measurements": [{"groupId": "OG000", "value": "58"}]}]}, {"title": "+1 Trivial", "categories": [{"measurements": [{"groupId": "OG000", "value": "20"}]}]}, {"title": "+2 Mild", "categories": [{"measurements": [{"groupId": "OG000", "value": "9"}]}]}, {"title": "+3 Moderate", "categories": [{"measurements": [{"groupId": "OG000", "value": "1"}]}]}, {"title": "+4 Severe", "categories": [{"measurements": [{"groupId": "OG000", "value": "0"}]}]}]}, {"type": "SECONDARY", "title": "Subject's Average White Blood Cell Count Measurement Over Time.", "description": "Laboratory analysis of White Blood Cell Count on blood drawn from subject; WBC fight infection.", "populationDescription": "The outcome is reported for subjects who received the Carpentier-Edwards PERIMOUNT Magna Ease, Model 3300TFX, device where data is available.", "reportingStatus": "POSTED", "paramType": "MEAN", "dispersionType": "Standard Deviation", "unitOfMeasure": "10^3 cells/microliters", "timeFrame": "6 months and annually for 8 years post-implant", "groups": [{"id": "OG000", "title": "Carpentier-Edwards\u00ae PERIMOUNT\u00ae Magna Ease\u2122, Model 3300TFX", "description": "Subjects who received the Carpentier-Edwards\u00ae PERIMOUNT\u00ae Magna Ease\u2122 valve, Model 3300TFX, undergoing isolated aortic valve replacement."}], "denoms": [{"units": "Participants", "counts": [{"groupId": "OG000", "value": "258"}]}], "classes": [{"title": "6 Months", "denoms": [{"units": "Participants", "counts": [{"groupId": "OG000", "value": "221"}]}], "categories": [{"measurements": [{"groupId": "OG000", "value": "7.0", "spread": "2.0"}]}]}, {"title": "1 Year", "denoms": [{"units": "Participants", "counts": [{"groupId": "OG000", "value": "218"}]}], "categories": [{"measurements": [{"groupId": "OG000", "value": "6.8", "spread": "1.7"}]}]}, {"title": "2 Years", "denoms": [{"units": "Participants", "counts": [{"groupId": "OG000", "value": "203"}]}], "categories": [{"measurements": [{"groupId": "OG000", "value": "6.9", "spread": "1.7"}]}]}, {"title": "3 Years", "denoms": [{"units": "Participants", "counts": [{"groupId": "OG000", "value": "200"}]}], "categories": [{"measurements": [{"groupId": "OG000", "value": "6.9", "spread": "2.1"}]}]}, {"title": "4 Years", "denoms": [{"units": "Participants", "counts": [{"groupId": "OG000", "value": "189"}]}], "categories": [{"measurements": [{"groupId": "OG000", "value": "6.9", "spread": "2.1"}]}]}, {"title": "5 Years", "denoms": [{"units": "Participants", "counts": [{"groupId": "OG000", "value": "178"}]}], "categories": [{"measurements": [{"groupId": "OG000", "value": "6.9", "spread": "1.7"}]}]}, {"title": "6 Years", "denoms": [{"units": "Participants", "counts": [{"groupId": "OG000", "value": "169"}]}], "categories": [{"measurements": [{"groupId": "OG000", "value": "7.1", "spread": "2.3"}]}]}, {"title": "7 Years", "denoms": [{"units": "Participants", "counts": [{"groupId": "OG000", "value": "125"}]}], "categories": [{"measurements": [{"groupId": "OG000", "value": "7.2", "spread": "1.6"}]}]}, {"title": "8 Years", "denoms": [{"units": "Participants", "counts": [{"groupId": "OG000", "value": "88"}]}], "categories": [{"measurements": [{"groupId": "OG000", "value": "7.4", "spread": "2.3"}]}]}]}, {"type": "SECONDARY", "title": "Subject's Average Red Blood Cells Count Over Time.", "description": "Laboratory Analysis of Red Blood Cell (RBC) Count on blood drawn from subjects; RBC carry oxygen.", "populationDescription": "The outcome is reported for subjects who received the Carpentier-Edwards PERIMOUNT Magna Ease, Model 3300TFX, device where data is available.", "reportingStatus": "POSTED", "paramType": "MEAN", "dispersionType": "Standard Deviation", "unitOfMeasure": "10^6 cells/microliters", "timeFrame": "6 months and annually for 8 years post-implant", "groups": [{"id": "OG000", "title": "Carpentier-Edwards\u00ae PERIMOUNT\u00ae Magna Ease\u2122, Model 3300TFX", "description": "Subjects who received the Carpentier-Edwards\u00ae PERIMOUNT\u00ae Magna Ease\u2122 valve, Model 3300TFX, undergoing isolated aortic valve replacement."}], "denoms": [{"units": "Participants", "counts": [{"groupId": "OG000", "value": "258"}]}], "classes": [{"title": "6 Months", "denoms": [{"units": "Participants", "counts": [{"groupId": "OG000", "value": "220"}]}], "categories": [{"measurements": [{"groupId": "OG000", "value": "4.7", "spread": "0.6"}]}]}, {"title": "1 Year", "denoms": [{"units": "Participants", "counts": [{"groupId": "OG000", "value": "218"}]}], "categories": [{"measurements": [{"groupId": "OG000", "value": "4.7", "spread": "0.6"}]}]}, {"title": "2 Years", "denoms": [{"units": "Participants", "counts": [{"groupId": "OG000", "value": "203"}]}], "categories": [{"measurements": [{"groupId": "OG000", "value": "4.7", "spread": "0.5"}]}]}, {"title": "3 Years", "denoms": [{"units": "Participants", "counts": [{"groupId": "OG000", "value": "200"}]}], "categories": [{"measurements": [{"groupId": "OG000", "value": "4.6", "spread": "0.5"}]}]}, {"title": "4 Years", "denoms": [{"units": "Participants", "counts": [{"groupId": "OG000", "value": "189"}]}], "categories": [{"measurements": [{"groupId": "OG000", "value": "4.6", "spread": "0.5"}]}]}, {"title": "5 Years", "denoms": [{"units": "Participants", "counts": [{"groupId": "OG000", "value": "178"}]}], "categories": [{"measurements": [{"groupId": "OG000", "value": "4.6", "spread": "0.6"}]}]}, {"title": "6 Years", "denoms": [{"units": "Participants", "counts": [{"groupId": "OG000", "value": "169"}]}], "categories": [{"measurements": [{"groupId": "OG000", "value": "4.6", "spread": "0.5"}]}]}, {"title": "7 Years", "denoms": [{"units": "Participants", "counts": [{"groupId": "OG000", "value": "125"}]}], "categories": [{"measurements": [{"groupId": "OG000", "value": "4.7", "spread": "0.6"}]}]}, {"title": "8 Years", "denoms": [{"units": "Participants", "counts": [{"groupId": "OG000", "value": "88"}]}], "categories": [{"measurements": [{"groupId": "OG000", "value": "4.7", "spread": "0.5"}]}]}]}, {"type": "SECONDARY", "title": "Subject's Average Hematocrit Percentage Over Time.", "description": "Laboratory Analysis of Hematocrit Percentage on blood drawn from subjects. Hematocrit is the proportion of red blood cells to the fluid component (plasma) in the blood.", "populationDescription": "The outcome is reported for subjects who received the Carpentier-Edwards PERIMOUNT Magna Ease, Model 3300TFX, device where data is available.", "reportingStatus": "POSTED", "paramType": "MEAN", "dispersionType": "Standard Deviation", "unitOfMeasure": "percentage of red blood cells", "timeFrame": "6 months and annually for 8 years post-implant", "groups": [{"id": "OG000", "title": "Carpentier-Edwards\u00ae PERIMOUNT\u00ae Magna Ease\u2122, Model 3300TFX", "description": "Subjects who received the Carpentier-Edwards\u00ae PERIMOUNT\u00ae Magna Ease\u2122 valve, Model 3300TFX, undergoing isolated aortic valve replacement."}], "denoms": [{"units": "Participants", "counts": [{"groupId": "OG000", "value": "258"}]}], "classes": [{"title": "6 Months", "denoms": [{"units": "Participants", "counts": [{"groupId": "OG000", "value": "221"}]}], "categories": [{"measurements": [{"groupId": "OG000", "value": "40.6", "spread": "4.0"}]}]}, {"title": "1 Year", "denoms": [{"units": "Participants", "counts": [{"groupId": "OG000", "value": "218"}]}], "categories": [{"measurements": [{"groupId": "OG000", "value": "41.2", "spread": "4.0"}]}]}, {"title": "2 Years", "denoms": [{"units": "Participants", "counts": [{"groupId": "OG000", "value": "203"}]}], "categories": [{"measurements": [{"groupId": "OG000", "value": "41.7", "spread": "4.0"}]}]}, {"title": "3 Years", "denoms": [{"units": "Participants", "counts": [{"groupId": "OG000", "value": "200"}]}], "categories": [{"measurements": [{"groupId": "OG000", "value": "41.4", "spread": "3.9"}]}]}, {"title": "4 Years", "denoms": [{"units": "Participants", "counts": [{"groupId": "OG000", "value": "188"}]}], "categories": [{"measurements": [{"groupId": "OG000", "value": "41.8", "spread": "4.1"}]}]}, {"title": "5 Years", "denoms": [{"units": "Participants", "counts": [{"groupId": "OG000", "value": "177"}]}], "categories": [{"measurements": [{"groupId": "OG000", "value": "41.6", "spread": "7.9"}]}]}, {"title": "6 Years", "denoms": [{"units": "Participants", "counts": [{"groupId": "OG000", "value": "169"}]}], "categories": [{"measurements": [{"groupId": "OG000", "value": "41.2", "spread": "5.3"}]}]}, {"title": "7 Years", "denoms": [{"units": "Participants", "counts": [{"groupId": "OG000", "value": "125"}]}], "categories": [{"measurements": [{"groupId": "OG000", "value": "41.4", "spread": "4.6"}]}]}, {"title": "8 Years", "denoms": [{"units": "Participants", "counts": [{"groupId": "OG000", "value": "88"}]}], "categories": [{"measurements": [{"groupId": "OG000", "value": "42.6", "spread": "6.6"}]}]}]}, {"type": "SECONDARY", "title": "Subject's Average Hemoglobin Count Over Time.", "description": "Laboratory Analysis of Hemoglobin Count on blood drawn from subjects. Hemoglobin is an oxygen-carrying protein in red blood cells.", "populationDescription": "The outcome is reported for subjects who received the Carpentier-Edwards PERIMOUNT Magna Ease, Model 3300TFX, device where data is available.", "reportingStatus": "POSTED", "paramType": "MEAN", "dispersionType": "Standard Deviation", "unitOfMeasure": "g/dl", "timeFrame": "6 months and annually for 8 years post-implant", "groups": [{"id": "OG000", "title": "Carpentier-Edwards\u00ae PERIMOUNT\u00ae Magna Ease\u2122, Model 3300TFX", "description": "Subjects who received the Carpentier-Edwards\u00ae PERIMOUNT\u00ae Magna Ease\u2122 valve, Model 3300TFX, undergoing isolated aortic valve replacement."}], "denoms": [{"units": "Participants", "counts": [{"groupId": "OG000", "value": "258"}]}], "classes": [{"title": "6 Months", "denoms": [{"units": "Participants", "counts": [{"groupId": "OG000", "value": "221"}]}], "categories": [{"measurements": [{"groupId": "OG000", "value": "13.7", "spread": "1.6"}]}]}, {"title": "1 Year", "denoms": [{"units": "Participants", "counts": [{"groupId": "OG000", "value": "218"}]}], "categories": [{"measurements": [{"groupId": "OG000", "value": "14.0", "spread": "1.6"}]}]}, {"title": "2 Years", "denoms": [{"units": "Participants", "counts": [{"groupId": "OG000", "value": "203"}]}], "categories": [{"measurements": [{"groupId": "OG000", "value": "14.1", "spread": "1.6"}]}]}, {"title": "3 Years", "denoms": [{"units": "Participants", "counts": [{"groupId": "OG000", "value": "200"}]}], "categories": [{"measurements": [{"groupId": "OG000", "value": "14.0", "spread": "1.5"}]}]}, {"title": "4 Years", "denoms": [{"units": "Participants", "counts": [{"groupId": "OG000", "value": "189"}]}], "categories": [{"measurements": [{"groupId": "OG000", "value": "14.1", "spread": "1.5"}]}]}, {"title": "5 Years", "denoms": [{"units": "Participants", "counts": [{"groupId": "OG000", "value": "177"}]}], "categories": [{"measurements": [{"groupId": "OG000", "value": "14.0", "spread": "1.6"}]}]}, {"title": "6 Years", "denoms": [{"units": "Participants", "counts": [{"groupId": "OG000", "value": "169"}]}], "categories": [{"measurements": [{"groupId": "OG000", "value": "14.0", "spread": "1.7"}]}]}, {"title": "7 Years", "denoms": [{"units": "Participants", "counts": [{"groupId": "OG000", "value": "125"}]}], "categories": [{"measurements": [{"groupId": "OG000", "value": "14.0", "spread": "1.8"}]}]}, {"title": "8 Years", "denoms": [{"units": "Participants", "counts": [{"groupId": "OG000", "value": "88"}]}], "categories": [{"measurements": [{"groupId": "OG000", "value": "14.3", "spread": "1.4"}]}]}]}, {"type": "SECONDARY", "title": "Subject's Average Platelet Count Over Time.", "description": "Laboratory Analysis of Platelet Count on blood drawn from subjects; platelets help with blood clotting.", "populationDescription": "The outcome is reported for subjects who received the Carpentier-Edwards PERIMOUNT Magna Ease, Model 3300TFX, device where data is available.", "reportingStatus": "POSTED", "paramType": "MEAN", "dispersionType": "Standard Deviation", "unitOfMeasure": "10^3 platelets per microliter", "timeFrame": "6 months and annually for 8 years post-implant", "groups": [{"id": "OG000", "title": "Carpentier-Edwards\u00ae PERIMOUNT\u00ae Magna Ease\u2122, Model 3300TFX", "description": "Subjects who received the Carpentier-Edwards\u00ae PERIMOUNT\u00ae Magna Ease\u2122 valve, Model 3300TFX, undergoing isolated aortic valve replacement."}], "denoms": [{"units": "Participants", "counts": [{"groupId": "OG000", "value": "258"}]}], "classes": [{"title": "6 Months", "denoms": [{"units": "Participants", "counts": [{"groupId": "OG000", "value": "220"}]}], "categories": [{"measurements": [{"groupId": "OG000", "value": "207.9", "spread": "64.4"}]}]}, {"title": "1 Year", "denoms": [{"units": "Participants", "counts": [{"groupId": "OG000", "value": "218"}]}], "categories": [{"measurements": [{"groupId": "OG000", "value": "202.5", "spread": "50.1"}]}]}, {"title": "2 Years", "denoms": [{"units": "Participants", "counts": [{"groupId": "OG000", "value": "202"}]}], "categories": [{"measurements": [{"groupId": "OG000", "value": "204.7", "spread": "56.3"}]}]}, {"title": "3 Years", "denoms": [{"units": "Participants", "counts": [{"groupId": "OG000", "value": "200"}]}], "categories": [{"measurements": [{"groupId": "OG000", "value": "195.6", "spread": "50.9"}]}]}, {"title": "4 Years", "denoms": [{"units": "Participants", "counts": [{"groupId": "OG000", "value": "188"}]}], "categories": [{"measurements": [{"groupId": "OG000", "value": "198.6", "spread": "57.1"}]}]}, {"title": "5 Years", "denoms": [{"units": "Participants", "counts": [{"groupId": "OG000", "value": "178"}]}], "categories": [{"measurements": [{"groupId": "OG000", "value": "198.3", "spread": "74.7"}]}]}, {"title": "6 Years", "denoms": [{"units": "Participants", "counts": [{"groupId": "OG000", "value": "169"}]}], "categories": [{"measurements": [{"groupId": "OG000", "value": "196.9", "spread": "54.7"}]}]}, {"title": "7 Years", "denoms": [{"units": "Participants", "counts": [{"groupId": "OG000", "value": "125"}]}], "categories": [{"measurements": [{"groupId": "OG000", "value": "199.1", "spread": "58.3"}]}]}, {"title": "8 Years", "denoms": [{"units": "Participants", "counts": [{"groupId": "OG000", "value": "88"}]}], "categories": [{"measurements": [{"groupId": "OG000", "value": "190.7", "spread": "51.1"}]}]}]}, {"type": "SECONDARY", "title": "Subject's Average Serum Lactate Dehydrogenase (LDH) Over Time.", "description": "Laboratory Analysis of Serum Lactate Dehydrogenase on blood drawn from subjects; The lactate dehydrogenase (LDH) test looks for signs of damage to the body's tissues.", "populationDescription": "The outcome is reported for subjects who received the Carpentier-Edwards PERIMOUNT Magna Ease, Model 3300TFX, device where data is available.", "reportingStatus": "POSTED", "paramType": "MEAN", "dispersionType": "Standard Deviation", "unitOfMeasure": "U/L", "timeFrame": "6 months and annually for 8 years post-implant", "groups": [{"id": "OG000", "title": "Carpentier-Edwards\u00ae PERIMOUNT\u00ae Magna Ease\u2122, Model 3300TFX", "description": "Subjects who received the Carpentier-Edwards\u00ae PERIMOUNT\u00ae Magna Ease\u2122 valve, Model 3300TFX, undergoing isolated aortic valve replacement."}], "denoms": [{"units": "Participants", "counts": [{"groupId": "OG000", "value": "258"}]}], "classes": [{"title": "6 Months", "denoms": [{"units": "Participants", "counts": [{"groupId": "OG000", "value": "216"}]}], "categories": [{"measurements": [{"groupId": "OG000", "value": "240.8", "spread": "112.6"}]}]}, {"title": "1 Year", "denoms": [{"units": "Participants", "counts": [{"groupId": "OG000", "value": "217"}]}], "categories": [{"measurements": [{"groupId": "OG000", "value": "235.5", "spread": "103.3"}]}]}, {"title": "2 Years", "denoms": [{"units": "Participants", "counts": [{"groupId": "OG000", "value": "198"}]}], "categories": [{"measurements": [{"groupId": "OG000", "value": "234.6", "spread": "106.5"}]}]}, {"title": "3 Years", "denoms": [{"units": "Participants", "counts": [{"groupId": "OG000", "value": "197"}]}], "categories": [{"measurements": [{"groupId": "OG000", "value": "236.1", "spread": "102.3"}]}]}, {"title": "4 Years", "denoms": [{"units": "Participants", "counts": [{"groupId": "OG000", "value": "187"}]}], "categories": [{"measurements": [{"groupId": "OG000", "value": "243.9", "spread": "107.1"}]}]}, {"title": "5 Years", "denoms": [{"units": "Participants", "counts": [{"groupId": "OG000", "value": "171"}]}], "categories": [{"measurements": [{"groupId": "OG000", "value": "236.7", "spread": "94.3"}]}]}, {"title": "6 Years", "denoms": [{"units": "Participants", "counts": [{"groupId": "OG000", "value": "168"}]}], "categories": [{"measurements": [{"groupId": "OG000", "value": "255.3", "spread": "162.2"}]}]}, {"title": "7 Years", "denoms": [{"units": "Participants", "counts": [{"groupId": "OG000", "value": "122"}]}], "categories": [{"measurements": [{"groupId": "OG000", "value": "238.2", "spread": "88.5"}]}]}, {"title": "8 Years", "denoms": [{"units": "Participants", "counts": [{"groupId": "OG000", "value": "86"}]}], "categories": [{"measurements": [{"groupId": "OG000", "value": "263.0", "spread": "117.9"}]}]}]}, {"type": "SECONDARY", "title": "Subject's Average Haptoglobin Measurement Over Time.", "description": "Laboratory Analysis of haptoglobin on blood drawn from subjects; haptoglobin is a protein produced by the liver.", "populationDescription": "The outcome is reported for subjects who received the Carpentier-Edwards PERIMOUNT Magna Ease, Model 3300TFX, device where data is available.", "reportingStatus": "POSTED", "paramType": "MEAN", "dispersionType": "Standard Deviation", "unitOfMeasure": "mg/dl", "timeFrame": "6 months and annually for 8 years post-implant", "groups": [{"id": "OG000", "title": "Carpentier-Edwards\u00ae PERIMOUNT\u00ae Magna Ease\u2122, Model 3300TFX", "description": "Subjects who received the Carpentier-Edwards\u00ae PERIMOUNT\u00ae Magna Ease\u2122 valve, Model 3300TFX, undergoing isolated aortic valve replacement."}], "denoms": [{"units": "Participants", "counts": [{"groupId": "OG000", "value": "258"}]}], "classes": [{"title": "6 Months", "denoms": [{"units": "Participants", "counts": [{"groupId": "OG000", "value": "204"}]}], "categories": [{"measurements": [{"groupId": "OG000", "value": "118.4", "spread": "66.9"}]}]}, {"title": "1 Year", "denoms": [{"units": "Participants", "counts": [{"groupId": "OG000", "value": "203"}]}], "categories": [{"measurements": [{"groupId": "OG000", "value": "114.7", "spread": "70.7"}]}]}, {"title": "2 Years", "denoms": [{"units": "Participants", "counts": [{"groupId": "OG000", "value": "188"}]}], "categories": [{"measurements": [{"groupId": "OG000", "value": "115.6", "spread": "61.4"}]}]}, {"title": "3 Years", "denoms": [{"units": "Participants", "counts": [{"groupId": "OG000", "value": "181"}]}], "categories": [{"measurements": [{"groupId": "OG000", "value": "116.3", "spread": "58.9"}]}]}, {"title": "4 Years", "denoms": [{"units": "Participants", "counts": [{"groupId": "OG000", "value": "169"}]}], "categories": [{"measurements": [{"groupId": "OG000", "value": "112.8", "spread": "62.3"}]}]}, {"title": "5 Years", "denoms": [{"units": "Participants", "counts": [{"groupId": "OG000", "value": "159"}]}], "categories": [{"measurements": [{"groupId": "OG000", "value": "127.1", "spread": "104.0"}]}]}, {"title": "6 Years", "denoms": [{"units": "Participants", "counts": [{"groupId": "OG000", "value": "154"}]}], "categories": [{"measurements": [{"groupId": "OG000", "value": "115.6", "spread": "58.9"}]}]}, {"title": "7 Years", "denoms": [{"units": "Participants", "counts": [{"groupId": "OG000", "value": "107"}]}], "categories": [{"measurements": [{"groupId": "OG000", "value": "125.0", "spread": "87.4"}]}]}, {"title": "8 Years", "denoms": [{"units": "Participants", "counts": [{"groupId": "OG000", "value": "80"}]}], "categories": [{"measurements": [{"groupId": "OG000", "value": "109.8", "spread": "53.7"}]}]}]}, {"type": "SECONDARY", "title": "Subject's Average Reticulocytes Percentage Over Time.", "description": "Laboratory Analysis of reticulocytes on blood drawn from subjects. Reticulocytes are newly produced immature red blood cells; a reticulocyte blood test measures the amount of these cells in the blood.", "populationDescription": "The outcome is reported for subjects who received the Carpentier-Edwards PERIMOUNT Magna Ease, Model 3300TFX, device where data is available.", "reportingStatus": "POSTED", "paramType": "MEAN", "dispersionType": "Standard Deviation", "unitOfMeasure": "percentage of reticulocytes", "timeFrame": "6 months and annually for 8 years post-implant", "groups": [{"id": "OG000", "title": "Carpentier-Edwards\u00ae PERIMOUNT\u00ae Magna Ease\u2122, Model 3300TFX", "description": "Subjects who received the Carpentier-Edwards\u00ae PERIMOUNT\u00ae Magna Ease\u2122 valve, Model 3300TFX, undergoing isolated aortic valve replacement."}], "denoms": [{"units": "Participants", "counts": [{"groupId": "OG000", "value": "258"}]}], "classes": [{"title": "6 Months", "denoms": [{"units": "Participants", "counts": [{"groupId": "OG000", "value": "214"}]}], "categories": [{"measurements": [{"groupId": "OG000", "value": "1.2", "spread": "1.5"}]}]}, {"title": "1 Year", "denoms": [{"units": "Participants", "counts": [{"groupId": "OG000", "value": "214"}]}], "categories": [{"measurements": [{"groupId": "OG000", "value": "1.2", "spread": "0.5"}]}]}, {"title": "2 Years", "denoms": [{"units": "Participants", "counts": [{"groupId": "OG000", "value": "199"}]}], "categories": [{"measurements": [{"groupId": "OG000", "value": "1.2", "spread": "0.5"}]}]}, {"title": "3 Years", "denoms": [{"units": "Participants", "counts": [{"groupId": "OG000", "value": "196"}]}], "categories": [{"measurements": [{"groupId": "OG000", "value": "1.2", "spread": "0.5"}]}]}, {"title": "4 Years", "denoms": [{"units": "Participants", "counts": [{"groupId": "OG000", "value": "186"}]}], "categories": [{"measurements": [{"groupId": "OG000", "value": "1.4", "spread": "1.3"}]}]}, {"title": "5 Years", "denoms": [{"units": "Participants", "counts": [{"groupId": "OG000", "value": "170"}]}], "categories": [{"measurements": [{"groupId": "OG000", "value": "1.8", "spread": "6.2"}]}]}, {"title": "6 Years", "denoms": [{"units": "Participants", "counts": [{"groupId": "OG000", "value": "168"}]}], "categories": [{"measurements": [{"groupId": "OG000", "value": "4.4", "spread": "13.4"}]}]}, {"title": "7 Years", "denoms": [{"units": "Participants", "counts": [{"groupId": "OG000", "value": "121"}]}], "categories": [{"measurements": [{"groupId": "OG000", "value": "5.4", "spread": "16.5"}]}]}, {"title": "8 Years", "denoms": [{"units": "Participants", "counts": [{"groupId": "OG000", "value": "84"}]}], "categories": [{"measurements": [{"groupId": "OG000", "value": "4.5", "spread": "14.8"}]}]}]}, {"type": "SECONDARY", "title": "Subject's Average Score on the EQ-5D- Quality of Life Questionnaire at Baseline and 6 Months Post-Implant.", "description": "The EQ-5D is a standardized questionnaire that asks subjects to rate themselves (no problems, some problems, extreme problems) on mobility, self-care, usual activities, pain/discomfort, and anxiety/depression. The scale ranges from a minimum of 0 and a maximum of 100 where zero is the 'worst state imaginable' and 100 is the 'best state imaginable'.", "populationDescription": "The outcome is reported for subjects who received the Carpentier-Edwards PERIMOUNT Magna Ease, Model 3300TFX, device where data is available.", "reportingStatus": "POSTED", "paramType": "MEAN", "dispersionType": "Standard Deviation", "unitOfMeasure": "units on a scale", "timeFrame": "Baseline and 6 Months Post-Implant", "groups": [{"id": "OG000", "title": "Carpentier-Edwards\u00ae PERIMOUNT\u00ae Magna Ease\u2122, Model 3300TFX", "description": "Subjects who received the Carpentier-Edwards\u00ae PERIMOUNT\u00ae Magna Ease\u2122 valve, Model 3300TFX, undergoing isolated aortic valve replacement."}], "denoms": [{"units": "Participants", "counts": [{"groupId": "OG000", "value": "96"}]}], "classes": [{"title": "Baseline", "categories": [{"measurements": [{"groupId": "OG000", "value": "75.8", "spread": "15.1"}]}]}, {"title": "6 Months Follow-up", "categories": [{"measurements": [{"groupId": "OG000", "value": "84.3", "spread": "13.6"}]}]}]}]}, "adverseEventsModule": {"frequencyThreshold": "0", "timeFrame": "Events occurring from baseline through eight years post implant.", "description": "The outcome is reported for subjects who received the Carpentier-Edwards PERIMOUNT Magna Ease Pericardial Bioprosthesis, Model 3300TFX device where data is available.", "eventGroups": [{"id": "EG000", "title": "Carpentier-Edwards\u00ae PERIMOUNT\u00ae Magna Ease\u2122, Model 3300TFX", "description": "Subjects who received the Carpentier-Edwards\u00ae PERIMOUNT\u00ae Magna Ease\u2122 valve, Model 3300TFX, undergoing isolated aortic valve replacement.", "deathsNumAffected": 38, "deathsNumAtRisk": 258, "seriousNumAffected": 211, "seriousNumAtRisk": 258, "otherNumAffected": 184, "otherNumAtRisk": 258}], "seriousEvents": [{"term": "Anemia", "organSystem": "Blood and lymphatic system disorders", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numEvents": 23, "numAffected": 20, "numAtRisk": 258}]}, {"term": "Angina", "organSystem": "Cardiac disorders", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numEvents": 16, "numAffected": 11, "numAtRisk": 258}]}, {"term": "Arrhythmia", "organSystem": "Cardiac disorders", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numEvents": 101, "numAffected": 87, "numAtRisk": 258}]}, {"term": "Bleeding - Major", "organSystem": "Blood and lymphatic system disorders", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numEvents": 34, "numAffected": 32, "numAtRisk": 258}]}, {"term": "Bleeding - Minor", "organSystem": "Blood and lymphatic system disorders", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numEvents": 12, "numAffected": 12, "numAtRisk": 258}]}, {"term": "Bone Fracture", "organSystem": "Musculoskeletal and connective tissue disorders", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numEvents": 9, "numAffected": 9, "numAtRisk": 258}]}, {"term": "Cancer", "organSystem": "General disorders", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numEvents": 39, "numAffected": 27, "numAtRisk": 258}]}, {"term": "Cardiac Arrest", "organSystem": "Cardiac disorders", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numEvents": 2, "numAffected": 2, "numAtRisk": 258}]}, {"term": "Cardiac Conduction Disturbance", "organSystem": "Cardiac disorders", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numEvents": 6, "numAffected": 6, "numAtRisk": 258}]}, {"term": "Cardiac Failure", "organSystem": "Cardiac disorders", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numEvents": 17, "numAffected": 14, "numAtRisk": 258}]}, {"term": "Cardiovascular - Other", "organSystem": "Cardiac disorders", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numEvents": 11, "numAffected": 11, "numAtRisk": 258}]}, {"term": "Cardiovascular Dissection / Tear / Injury", "organSystem": "Cardiac disorders", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numEvents": 1, "numAffected": 1, "numAtRisk": 258}]}, {"term": "Coagulopathy", "organSystem": "Blood and lymphatic system disorders", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numEvents": 1, "numAffected": 1, "numAtRisk": 258}]}, {"term": "Drug Reaction", "organSystem": "General disorders", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numEvents": 3, "numAffected": 3, "numAtRisk": 258}]}, {"term": "Edema", "organSystem": "Musculoskeletal and connective tissue disorders", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numEvents": 1, "numAffected": 1, "numAtRisk": 258}]}, {"term": "Endocarditis", "organSystem": "Cardiac disorders", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numEvents": 6, "numAffected": 6, "numAtRisk": 258}]}, {"term": "Fever - Unknown Origin", "organSystem": "General disorders", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numEvents": 3, "numAffected": 2, "numAtRisk": 258}]}, {"term": "Gastro-Intestinal Complication", "organSystem": "Gastrointestinal disorders", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numEvents": 32, "numAffected": 26, "numAtRisk": 258}]}, {"term": "Hematological Disorder", "organSystem": "Blood and lymphatic system disorders", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numEvents": 8, "numAffected": 6, "numAtRisk": 258}]}, {"term": "Hepatic Complication", "organSystem": "Gastrointestinal disorders", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numEvents": 3, "numAffected": 3, "numAtRisk": 258}]}, {"term": "Hypotension", "organSystem": "Cardiac disorders", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numEvents": 2, "numAffected": 2, "numAtRisk": 258}]}, {"term": "Infection / Inflammation", "organSystem": "Infections and infestations", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numEvents": 54, "numAffected": 40, "numAtRisk": 258}]}, {"term": "Metabolic Complication", "organSystem": "Metabolism and nutrition disorders", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numEvents": 3, "numAffected": 3, "numAtRisk": 258}]}, {"term": "Mitral Regurgitation (Native)", "organSystem": "Cardiac disorders", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numEvents": 1, "numAffected": 1, "numAtRisk": 258}]}, {"term": "Multiple Organ Failure", "organSystem": "General disorders", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numEvents": 5, "numAffected": 5, "numAtRisk": 258}]}, {"term": "Myocardial Infarct", "organSystem": "Cardiac disorders", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numEvents": 7, "numAffected": 7, "numAtRisk": 258}]}, {"term": "NSVD - Other non-structural valve dysfunction", "organSystem": "Cardiac disorders", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numEvents": 1, "numAffected": 1, "numAtRisk": 258}]}, {"term": "NSVD - Paravalvular Leak - Major", "organSystem": "Cardiac disorders", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numEvents": 2, "numAffected": 2, "numAtRisk": 258}]}, {"term": "NSVD - Paravalvular Leak - Minor", "organSystem": "Cardiac disorders", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numEvents": 1, "numAffected": 1, "numAtRisk": 258}]}, {"term": "Neurological Complication", "organSystem": "Psychiatric disorders", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numEvents": 8, "numAffected": 8, "numAtRisk": 258}]}, {"term": "Other", "organSystem": "General disorders", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numEvents": 99, "numAffected": 63, "numAtRisk": 258}]}, {"term": "Pericardial Effusion", "organSystem": "Cardiac disorders", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numEvents": 21, "numAffected": 20, "numAtRisk": 258}]}, {"term": "Pleural Effusion", "organSystem": "Cardiac disorders", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numEvents": 37, "numAffected": 37, "numAtRisk": 258}]}, {"term": "Pneumothorax / Hemothorax", "organSystem": "Cardiac disorders", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numEvents": 1, "numAffected": 1, "numAtRisk": 258}]}, {"term": "Psychiatric Complication", "organSystem": "Psychiatric disorders", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numEvents": 6, "numAffected": 6, "numAtRisk": 258}]}, {"term": "Pulmonary Embolism", "organSystem": "Cardiac disorders", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numEvents": 3, "numAffected": 3, "numAtRisk": 258}]}, {"term": "Renal Complication", "organSystem": "Renal and urinary disorders", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numEvents": 6, "numAffected": 6, "numAtRisk": 258}]}, {"term": "Respiratory Complication", "organSystem": "Respiratory, thoracic and mediastinal disorders", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numEvents": 30, "numAffected": 27, "numAtRisk": 258}]}, {"term": "SVD - Other structural valve deterioration", "organSystem": "Cardiac disorders", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numEvents": 8, "numAffected": 8, "numAtRisk": 258}]}, {"term": "SVD - Study valve calcification", "organSystem": "Cardiac disorders", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numEvents": 2, "numAffected": 2, "numAtRisk": 258}]}, {"term": "Septicemia", "organSystem": "Blood and lymphatic system disorders", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numEvents": 7, "numAffected": 5, "numAtRisk": 258}]}, {"term": "Sternal / Thoracic Wound Complication", "organSystem": "Musculoskeletal and connective tissue disorders", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numEvents": 12, "numAffected": 9, "numAtRisk": 258}]}, {"term": "Sudden Death", "organSystem": "General disorders", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numEvents": 2, "numAffected": 2, "numAtRisk": 258}]}, {"term": "Syncope", "organSystem": "Cardiac disorders", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numEvents": 3, "numAffected": 2, "numAtRisk": 258}]}, {"term": "Thromboembolism - Non-cerebral", "organSystem": "Cardiac disorders", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numEvents": 1, "numAffected": 1, "numAtRisk": 258}]}, {"term": "Thromboembolism - Stroke", "organSystem": "Cardiac disorders", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numEvents": 13, "numAffected": 13, "numAtRisk": 258}]}, {"term": "Thromboembolism - TIA", "organSystem": "Cardiac disorders", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numEvents": 6, "numAffected": 6, "numAtRisk": 258}]}, {"term": "Urinary Tract Infection", "organSystem": "Renal and urinary disorders", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numEvents": 3, "numAffected": 3, "numAtRisk": 258}]}, {"term": "Vascular Complication", "organSystem": "Cardiac disorders", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numEvents": 13, "numAffected": 9, "numAtRisk": 258}]}, {"term": "Vision Disorder", "organSystem": "Eye disorders", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numEvents": 10, "numAffected": 8, "numAtRisk": 258}]}], "otherEvents": [{"term": "Abnormal Lab Values", "organSystem": "Eye disorders", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numEvents": 7, "numAffected": 7, "numAtRisk": 258}]}, {"term": "Anemia", "organSystem": "Blood and lymphatic system disorders", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numEvents": 3, "numAffected": 3, "numAtRisk": 258}]}, {"term": "Angina", "organSystem": "Cardiac disorders", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numEvents": 6, "numAffected": 4, "numAtRisk": 258}]}, {"term": "Arrhythmia", "organSystem": "Cardiac disorders", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numEvents": 80, "numAffected": 58, "numAtRisk": 258}]}, {"term": "Atelectasis", "organSystem": "Respiratory, thoracic and mediastinal disorders", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numEvents": 1, "numAffected": 1, "numAtRisk": 258}]}, {"term": "Bleeding - Minor", "organSystem": "Blood and lymphatic system disorders", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numEvents": 13, "numAffected": 12, "numAtRisk": 258}]}, {"term": "Bone Fracture", "organSystem": "Musculoskeletal and connective tissue disorders", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numEvents": 7, "numAffected": 7, "numAtRisk": 258}]}, {"term": "Cancer", "organSystem": "General disorders", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numEvents": 4, "numAffected": 4, "numAtRisk": 258}]}, {"term": "Cardiac Conduction Disturbance", "organSystem": "Cardiac disorders", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numEvents": 15, "numAffected": 15, "numAtRisk": 258}]}, {"term": "Cardiac Failure", "organSystem": "Cardiac disorders", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numEvents": 2, "numAffected": 2, "numAtRisk": 258}]}, {"term": "Cardiovascular - Other", "organSystem": "Cardiac disorders", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numEvents": 8, "numAffected": 7, "numAtRisk": 258}]}, {"term": "Drug Reaction", "organSystem": "General disorders", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numEvents": 1, "numAffected": 1, "numAtRisk": 258}]}, {"term": "Edema", "organSystem": "Musculoskeletal and connective tissue disorders", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numEvents": 2, "numAffected": 2, "numAtRisk": 258}]}, {"term": "Fever - Unknown Origin", "organSystem": "General disorders", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numEvents": 5, "numAffected": 5, "numAtRisk": 258}]}, {"term": "Gastro-Intestinal Complication", "organSystem": "Gastrointestinal disorders", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numEvents": 10, "numAffected": 10, "numAtRisk": 258}]}, {"term": "Hematological Disorder", "organSystem": "Blood and lymphatic system disorders", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numEvents": 4, "numAffected": 3, "numAtRisk": 258}]}, {"term": "Hemolysis", "organSystem": "Cardiac disorders", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numEvents": 2, "numAffected": 2, "numAtRisk": 258}]}, {"term": "Hepatic Complication", "organSystem": "Hepatobiliary disorders", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numEvents": 2, "numAffected": 2, "numAtRisk": 258}]}, {"term": "Hypertension", "organSystem": "Cardiac disorders", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numEvents": 1, "numAffected": 1, "numAtRisk": 258}]}, {"term": "Hypotension", "organSystem": "Cardiac disorders", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numEvents": 1, "numAffected": 1, "numAtRisk": 258}]}, {"term": "Infection / Inflammation", "organSystem": "Infections and infestations", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numEvents": 48, "numAffected": 42, "numAtRisk": 258}]}, {"term": "Metabolic Complication", "organSystem": "Metabolism and nutrition disorders", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numEvents": 1, "numAffected": 1, "numAtRisk": 258}]}, {"term": "Myocardial Infarct", "organSystem": "Cardiac disorders", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numEvents": 2, "numAffected": 2, "numAtRisk": 258}]}, {"term": "NSVD - Paravalvular Leak - Minor", "organSystem": "Cardiac disorders", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numEvents": 1, "numAffected": 1, "numAtRisk": 258}]}, {"term": "Neurological Complication", "organSystem": "Nervous system disorders", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numEvents": 1, "numAffected": 1, "numAtRisk": 258}]}, {"term": "Other", "organSystem": "General disorders", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numEvents": 165, "numAffected": 84, "numAtRisk": 258}]}, {"term": "Pericardial Effusion", "organSystem": "Cardiac disorders", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numEvents": 17, "numAffected": 17, "numAtRisk": 258}]}, {"term": "Pleural Effusion", "organSystem": "Cardiac disorders", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numEvents": 37, "numAffected": 36, "numAtRisk": 258}]}, {"term": "Pneumothorax / Hemothorax", "organSystem": "Cardiac disorders", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numEvents": 3, "numAffected": 3, "numAtRisk": 258}]}, {"term": "Psychiatric Complication", "organSystem": "Psychiatric disorders", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numEvents": 2, "numAffected": 2, "numAtRisk": 258}]}, {"term": "Pulmonary Embolism", "organSystem": "Cardiac disorders", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numEvents": 1, "numAffected": 1, "numAtRisk": 258}]}, {"term": "Renal Complication", "organSystem": "Renal and urinary disorders", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numEvents": 7, "numAffected": 6, "numAtRisk": 258}]}, {"term": "Respiratory Complication", "organSystem": "Respiratory, thoracic and mediastinal disorders", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numEvents": 17, "numAffected": 15, "numAtRisk": 258}]}, {"term": "SVD - Other structural valve deterioration", "organSystem": "Cardiac disorders", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numEvents": 5, "numAffected": 5, "numAtRisk": 258}]}, {"term": "Septicemia", "organSystem": "Blood and lymphatic system disorders", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numEvents": 1, "numAffected": 1, "numAtRisk": 258}]}, {"term": "Sternal / Thoracic Wound Complication", "organSystem": "Musculoskeletal and connective tissue disorders", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numEvents": 3, "numAffected": 3, "numAtRisk": 258}]}, {"term": "Syncope", "organSystem": "Cardiac disorders", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numEvents": 7, "numAffected": 7, "numAtRisk": 258}]}, {"term": "Thromboembolism - Non-cerebral", "organSystem": "Cardiac disorders", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numEvents": 1, "numAffected": 1, "numAtRisk": 258}]}, {"term": "Thromboembolism - TIA", "organSystem": "Cardiac disorders", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numEvents": 5, "numAffected": 5, "numAtRisk": 258}]}, {"term": "Tricuspid Regurgitation (Native)", "organSystem": "Cardiac disorders", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numEvents": 1, "numAffected": 1, "numAtRisk": 258}]}, {"term": "Urinary Tract Infection", "organSystem": "Renal and urinary disorders", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numEvents": 3, "numAffected": 2, "numAtRisk": 258}]}, {"term": "Vascular Complication", "organSystem": "Cardiac disorders", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numEvents": 4, "numAffected": 4, "numAtRisk": 258}]}, {"term": "Vision Disorder", "organSystem": "Eye disorders", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numEvents": 13, "numAffected": 11, "numAtRisk": 258}]}]}, "moreInfoModule": {"certainAgreement": {"piSponsorEmployee": false, "restrictionType": "OTHER", "restrictiveAgreement": true, "otherDetails": "Publication of overall study results which have not been released requires written approval of Sponsor, but presentation of site-specific results can occur subject to review by Sponsor. Manuscripts will be submitted to Sponsor for review 60 days prior to submission of manuscript for publication/presentation. Sponsor may ask for a 90 day delay of submission of manuscripts for publication to protect proprietary information and filing of related patent applications."}, "pointOfContact": {"title": "Andrey Nersesov, Sr. Director of Clinical Affairs, Surgical Structural Heart", "organization": "Edwards Lifesciences, LLC", "email": "Andrey_Nersesov@edwards.com", "phone": "949-250-2500", "phoneExt": "0225"}}}, "documentSection": {"largeDocumentModule": {"largeDocs": [{"typeAbbrev": "Prot_SAP", "hasProtocol": true, "hasSap": true, "hasIcf": false, "label": "Study Protocol and Statistical Analysis Plan", "date": "2009-09-15", "uploadDate": "2020-01-22T18:03", "filename": "Prot_SAP_000.pdf", "size": 407361}]}}, "derivedSection": {"miscInfoModule": {"versionHolder": "2024-06-24"}, "conditionBrowseModule": {"meshes": [{"id": "D000003324", "term": "Coronary Artery Disease"}, {"id": "D000001024", "term": "Aortic Valve Stenosis"}, {"id": "D000001022", "term": "Aortic Valve Insufficiency"}, {"id": "D000082862", "term": "Aortic Valve Disease"}], "ancestors": [{"id": "D000006331", "term": "Heart Diseases"}, {"id": "D000002318", "term": "Cardiovascular Diseases"}, {"id": "D000003327", "term": "Coronary Disease"}, {"id": "D000017202", "term": "Myocardial Ischemia"}, {"id": "D000001161", "term": "Arteriosclerosis"}, {"id": "D000001157", "term": "Arterial Occlusive Diseases"}, {"id": "D000014652", "term": "Vascular Diseases"}, {"id": "D000006349", "term": "Heart Valve Diseases"}, {"id": "D000014694", "term": "Ventricular Outflow Obstruction"}], "browseLeaves": [{"id": "M6546", "name": "Coronary Artery Disease", "asFound": "Coronary Artery Disease", "relevance": "HIGH"}, {"id": "M6475", "name": "Constriction, Pathologic", "relevance": "LOW"}, {"id": "M4340", "name": "Aortic Valve Stenosis", "asFound": "Aortic Valve Stenosis", "relevance": "HIGH"}, {"id": "M9421", "name": "Heart Failure", "relevance": "LOW"}, {"id": "M19506", "name": "Myocardial Ischemia", "relevance": "LOW"}, {"id": "M6549", "name": "Coronary Disease", "relevance": "LOW"}, {"id": "M2379", "name": "Aortic Valve Disease", "asFound": "Aortic Valve Disorder", "relevance": "HIGH"}, {"id": "M4338", "name": "Aortic Valve Insufficiency", "asFound": "Aortic Valve Insufficiency", "relevance": "HIGH"}, {"id": "M9419", "name": "Heart Diseases", "relevance": "LOW"}, {"id": "M10543", "name": "Ischemia", "relevance": "LOW"}, {"id": "M4469", "name": "Arteriosclerosis", "relevance": "LOW"}, {"id": "M4465", "name": "Arterial Occlusive Diseases", "relevance": "LOW"}, {"id": "M17400", "name": "Vascular Diseases", "relevance": "LOW"}, {"id": "M9437", "name": "Heart Valve Diseases", "relevance": "LOW"}, {"id": "M17440", "name": "Ventricular Outflow Obstruction", "relevance": "LOW"}, {"id": "T449", "name": "Aortic Valve Stenosis", "asFound": "Aortic Valve Stenosis", "relevance": "HIGH"}], "browseBranches": [{"abbrev": "BC14", "name": "Heart and Blood Diseases"}, {"abbrev": "All", "name": "All Conditions"}, {"abbrev": "BC23", "name": "Symptoms and General Pathology"}, {"abbrev": "Rare", "name": "Rare Diseases"}]}}, "hasResults": true}